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Chapter 1 
Introduction 
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Introduction 
The Structure of Bone  Bone is a rigid mineralized organ and forms part of the human skeleton. It provides support and protection for sensitive internal organs and allows limb movement and locomotion. It also plays an important role in the metabolism of minerals such as calcium and phosphate,  and harbors the blood-forming bone marrow. Morphologically there are flat bones of the skull, long bones and short bones of the limbs, and irregularly shaped bones of the spine and pelvis. Macroscopically one can separate compact from cancelous or spongy bone. The compact bone forms the outer surface of bones and the diaphysis in long bones. Cancelous or spongy bone is a loose network of trabecular structures, which fills the metaphysis and epiphysis of long bones and enables the transmission and distribution of forces(1) (Figure 1). In between the trabecular structures and inside the central cavity formed by the compact bone resides the bone marrow, a loose tissue comprised of blood sinusoids and haematopoietic cells providing most of the cellular blood components. This arrangement of supportive structures and loose internal tissue allows bones to be very strong and very light at the same time.  
In microscopic appearance, the rapidly formed and unorganized woven bone can be distinguished from the highly organized and mature lamellar bone. Osteons, the organizational units of lamellar bone, consist of a central vessel surrounded by concentric circles of osteoid matrix(2). The osteoid matrix consists mainly of collagen and provides flexibility and elasticity(1), whereas highly structured deposits of calciumphosphate called hydroxyapatite(1, 3) impart rigidity and compressive strength. Specialized cells, the osteocytes (Figure 1), are encased in regular intervals in the osteoid matrix(4). Osteoblasts secreting new matrix and osteoclasts resorbing 
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mineralized matrix can be found attached to the surface of this matrix. These cell types are involved in the homeostasis of mature bone.  
 
Figure 1: Structure of long bones. Top: General division of long bones. Middle: Microstructure. Bottom: Rhodamine staining of osteon under light microscopy (left) and confocal microscopy (right). Central vessel (a) and embedded osteocytes (b) can be seen. Adapted from Rho et al.(1) and Kerschnitzki et al.(4). 
Embryological Development Bone forming tissues are derived from the mesoderm or a specialized part of the ectoderm named the neuroectoderm(5). The mesenchymal stem cells form bone by two processes called intramembranous and endochondral ossification(6). During intramembranous ossification, mesenchymal stem cells in the connective tissue differentiate into osteoblasts and begin secreting osteoid matrix, which calcifies and becomes lamellar bone. During endochondral ossification (Figure 2) on the other hand,  
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the cells aggregate and form cartilaginous structures, which are the rudimentary templates for the subsequent bone formation(7), The cartilage then undergoes a maturation process during which the central portion becomes hypertrophic, i.e. the cells expand drastically in volume and modify the matrix around them(7). Mesenchymal stem cells directly adjacent to the hypertrophic matrix form the perichondral bone collar through intramembranous ossification (6, 8). At the same time, vasculature is attracted towards the central portion and begins to invade the  hypertrophic cartilage. During this invasion, hypertrophic matrix calcifies and is replaced by woven bone (7, 9). From the center, this process continues towards both proximal and distal ends of the bone rudiment. Near both ends, secondary ossification centers appear and undergo the same process. Where two bones interface, a joint is formed and the bones are capped with hyaline cartilage. This hyaline cartilage appears similar to the rudimentary cartilage template, but evidence suggests that the mesenchymal progenitors and the process of formation are different (10, 11). At birth only a thin layer of cartilage rudiment remains between metaphysis and epiphysis and is responsible for the later bone growth.   
 
Figure 2: Principle of endochondral ossification. Adapted from Mackie et al.(7) 
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Growth of Long Bones The cartilage found in the epiphyseal gap has a defined hierarchical structure (9, 12) (Figure 3). Directly beneath the secondary ossification center of the epiphysis there is a zone of resting cartilage, which resembles the hyaline cartilage found in adult joints and contains few chondrocytes. The next zone contains a higher number of cells and is called the proliferative zone. Next to it is the pre-hypertrophic zone, in which the cells begin to oragnize in distinct columns. In the subsequent hypertrophic zone, cells increase in volume and modify the matrix, effectively elongating bone. In the final zone of remodeling, cells undergo apoptosis and the matrix calcifies, while osteoclasts and vessels invade and remove the calcified matrix from the other side, followed by osteoblasts which deposit osteoid matrix.  
 
Figure 3: Organization of the growth plate cartilage. Safranin-O staining with fast green counterstaining. Adapted from Kim et al.(13) 
It is assumed that the proliferating chondrocytes are similar to stem cells(12) in that one daughter cell continues proliferating while the other differentiates. Proliferation can be guided by both systemic and local signals. For example growth hormone (GH) is 
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secreted by the hypophysis and stimulates secretion of insulin-like growth factor 1(IGF-1) by liver cells and pre-hypertrophic chondrocytes, which in turn stimulates proliferating chondrocytes(7). Indian hedgehog (IHH) is produced by prehypertrophic chondrocytes and increases proliferation and hypertrophy.  On the other hand, parathyroid hormone related peptide (PTHrP) is mainly produced by proliferating chondrocytes and inhibits hypertrophy.  IHH can induce expression of PTHrP, whereas PTHrP suppresses IHH expression(14). In this way a negative feedback loop is formed (Figure 3), which minutely controls the maturation of the growth plate(15). Other signals such as Wingless/Int (Wnt) or bone morphogenic proteins (BMP) can promote chondrocyte proliferation, whereas fibroblast growth factor (FGF) can repress it(7). In the latter case achondroplasia, the most frequent disease leading to dwarfism, results from an overactivation of the FGF pathway(16).  
The chondrocytes secrete extracellular matrix which consists of aggrecan, glycosaminoglycans and collagen type II. Other proteins are found in lower concentrations and mainly aid the assembly of the matrix and its interconnections(7). Expression of these matrix components is absolutely dependent on Sox9 (sex determining region Y box 9)(6, 7) and can be stimulated by tumor growth factor beta (TGFb) superfamily members (TGFb-1, BMP-2) and FGF.  
Once the chondrocytes become hypertrophic through expression of Runt-related transcription factor 2 (Runx2)(9), they increase production of collagen type X, matrix metalloproteinase 13 (MMP-13), alkaline phosphatase (ALP) and IHH(14). Their volume increases up to 10 fold(17), though they do not necessarily degrade the ECM to make space(7).  Thyroxin is the most important systemic regulator of hypertrophy(18) and its local effect is most likely transmitted by Wnt signaling(19).  
The hypertrophic chondrocytes induce matrix mineralization through secretion of matrix vesicles, which contain akaline phosphatase and are able to nucleate 
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hydroxyapatite crystals (7, 20). They can actively communicate with the subsequently invading cells, for example by expressing vascular endothelial growth factor (VEGF) to attract endothelial cells(21), receptor aktivator of NF-kB ligand (RANKL) to attract and differentiate osteoclasts(22), and IHH / Wnt to induce osteoblast differentiation of attracted mesenchymal stem cells(6). At the end of hypertrophy, most hypertrophic chondrocytes undergo apoptosis(7) and few transdifferentiate towards osteoblasts and osteocytes(23). 
 The hypertrophic matrix is degraded by apoptotic hypertrophic chondrocytes and osteoclasts (24, 25) through secretion of MMP-13 and MMP-9 respectively (21, 26). Endothelial cells(7) or macrophages(27) can aid matrix degradation and may increase MMP-9 expression if MMP-13 is absent(28). The degradation of the matrix releases factors which attract additional osteoclasts, endothelial cells and mesenchymal progenitors(29).  
When the bone growth finishes during young adulthood, the growth plate closes due to the influence of oestrogens, which deplete the pool of proliferating chondrocytes (7, 30). 
Homeostasis of Mature Bone  According to Wolff’s law bone tissue adapts to the mechanical stresses it is exposed to(31). This is possible through a constant buildup and degradation of bone by osteoblasts, osteocytes and osteoclasts (Figure 4). 
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Figure 4: Bone homeostasis. RANKL = receptor activator of NF-kB ligand. OPG = Osteoprotegerin. SOST = sclerostin. 
Osteoblasts are derived from mesenchymal stem cells and normally found as a cuboid eptihelium attached to bone(6). They begin differentiating by transiently expressing Sox9, followed by upregulation of Runx2, osterix (OSX) and finally activating transcription factor 4 (ATF4). These stages of development are regulated by Hedgehog, Notch, Wnt, BMP and FGF signaling(6). Sclerostin (SOST) can inhibit osteoblast formation(6). Osteoblasts secrete large amounts of collagen type I as well as a variety of extracellular matrix proteins(32). They also produce matrix vesicles containing alkaline phosphatase(33), which catalyzes the formation of hydroxyapatite and plays a crucial role during calcification (33, 34). The final product of osteoblasts is a regular wall of hydroxyapatite «bricks » surrounded by and connected with fibres of extracellular matrix creating a robust and at the same time flexible material. The osteoblasts may either undergo apoptosis, become bone lining cells or differentiate further into osteocytes(6).  
Osteocytes are the main regulators of bone turnover(35). They are found in lacunae inside the osteoid matrix and express a similar range of proteins compared to osteoblasts(35) which may enable them to locally repair the matrix. A more important 
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regulatory mechanism involves multiple osteocytes, connected to each other and to the extracellular space outside the bone matrix through a manifold of small channels called the canalicular network. Through this network, thin cellular appendages of each osteocyte connect to others by gap junctions and exchange signals about the general well-being of bone. Mechanical stresses are transferred to the single osteocytes through fluid displacements inside the canalicular network (36, 37). The fluid displacements lead to changes in levels of SOST, RANKL,  osteoprotegerin (OPG) and other factors(35), resulting in bone deposition or resorption. Apoptosis of osteocytes due to estrogen deprivation, physical inactivity, old age or just loss of contact with other osteocytes can lead to bone loss due to excessive release of RANKL(35).  
Bone is resorbed by osteoclasts, giant multinucleated cells which share a common progenitor with macrophages, dendritic cells and giant foreign body cells (38, 39). When the right signals such as macrophage colony stimulating factor (M-CSF) and RANKL are present(40), mononcytes coming from the bone marrow, periost or peripheral blood migrate towards the chemoattractive gradient and fuse together. The new multinucleated cell attaches firmly to the bone surface and seals off a small space. In this space it will pump H+ ions and enzymes such as tartrate resistant acid phosphatase(TRAP) or cathepsin K, which are capable of dissolving hydroxyapatite and also the underlying collagenous extracellular matrix (41, 42). MMPs have a very minor role in this bone resorption(43). The products of the resorption are released by the osteoclast into the extracellular fluid and may directly couple resorption to the bone formation of osteoblasts(44).  For example TGFb-1, which is stored in a latent form in the bone matrix, is released and activated through the osteoclasts to attract osteoblasts (45, 46). Osteoclasts themselves also produce factors such as BMP-6, Wnt-10b, sphingosine-1-phosphate (S1P)(44) and collagen triple helix repeat containing protein 1 (CTHRC1)(47) which stimulate bone matrix deposition by osteoblasts. Osteoblasts and 
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osteocytes can inhibit osteoclast resorption through release of OPG, a decoy receptor for RANKL(48). 
Fracture Healing Bone is the only tissue of the human body which can completely heal without any scar formation. However, this is only possible if conditions are just right. Two distinct processes of fracture healing can occur. If there is a clean break, the two fragments are not separated by more than 0.01mm and no movement occurs, new osteons will form at both ends and continue the process of homeostasis detailed above(49). The fracture will thus be bridged by many new osteoid laminae.  
If the fracture is complex, separated by a large gap or subjected to much movement, a process similar to endochondral ossification begins (49, 50). In the first stage, the fracture gap is filled by blood from the ruptured vessels and bone marrow cavity. The blood coagulates and stabilizes the fracture site. The blood clot is rapidly invaded by a wave of neutrophils(51) followed by macrophages and mesenchymal stem cells. The latter begin differentiating to chondrocytes and form a type of disorganized fibrocartilage which represents the soft fracture callus (Figure 5). This tissue has better mechanical properties than the blood clot and is able to stabilize the fracture(52). Intriguingly, instead of disorganized tissue, a peculiar type of growth plate may sometimes form and help to realign the fracture fragments(53). The fibrocartilage becomes hypertrophic and undergoes endochondral ossification as detailed above. The tissue calcifies, is invaded by vessels and replaced by osteoid matrix. In particular, the outside shell is replaced by cortical bone, whereas the interior of the callus is replaced with bone marrow and trabecular structures (Figure 5). After the callus has ossified, the process of bone homeostasis will reshape it according to the mechanical loads and stresses, until an approximately ideal shape is reached. The final shape depends on the 
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previous alignment of the fracture fragments and on the age of the person and may take several years to be fully reached(49). 
 
Figure 5: Fracture healing through endochondral ossification, safranin-O and fast green staining. Modified from Ai-Aql et al.(54) 
Enhancing Bone Regeneration 
Clinical Procedures in Fracture Repair In realistical clinical situations, bone regeneration is often not possible without additional outside help. Fractures, bone loss or osteotomies after tumor removal can often be treated through stabilization and supportive management. Surgeons first need to adapt the fragments to replicate the correct alignment. They can then stabilize the fracture either by a cast or by applying internal or external fixation. Internal fixation can be performed by inserting a nail in the intramedullar cavity or bridging the defect by a combination of screws and plates. External fixation involves placing screws through the skin and connecting them with plates outside the body(55-57). However, not every defect in every patient can be anatomically adapted using only these tools. 
If a large bone volume is missing, other techniques of bone generation have to be applied.  Distraction osteogenesis is one possibility, where fragments are brought together to heal and subsequently distracted slowly with an internal or external device. This approach is very time- and cost-intensive and leads to problems such as secondary 
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fractures, neurovascular difficulties and psychological stigma(58). Another possibility is the Masquelet technique, for which a cement spacer is inserted into the stabilized bone defect and left until an « induced membrane » with additional vasculature has formed. In a second procedure, the cement is replaced by autologous bone chips(59). This technique requires two surgeries and autologous bone extraction and is often accompanied by infection of the fracture.  
If the conditions of fracture healing are not optimal, a non-union can develop. The bone fragments thus never join, either because of insufficient stabilization, insufficient vascularization, inflammatory or infectious processes or metabolic problems(60).  
If the patient has an underlying pathology such as osteoporosis, the fracture fixation can already become problematic and require the augmentation of bone volume(61). 
Large missing bone volumes,  non-unions and treatment of osteoporotic fractures are thus challenging clinical scenarios, for which a suitable bone graft is necessary.  
Transplantation of Bones The currently most suitable bone graft for the above mentioned challenges is autologous bone. It can be used as a bone filling material or prepared together with its blood supply and transplanted. Bone tissue for a fracture augmentation is most commonly taken from the illiac crest, where part of the bone is cut out, crushed and implanted in the fracture site(62). Large segmental defects can be treated with a vascularized bone piece, for example by extracting part of the fibula together with its blood supply and re-attaching it at the fracture site(63). With both approaches, difficulties arise due to limited availability, donor site morbidity and costs. Although transplantation of allogeneic bone from cadavers is possible, it is rarely used due to the difficulty of screening for infections in bone tissue and the necessity to suppress a possible immune response(64, 65). 
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Bone Substitutes The drawbacks of bone transplantation have led to the development of a variatey of off-the-shelf bone substitute materials. Three major types of materials are categorized according to their mode of action(66). Osteoconductive materials provide a scaffold on which host derived osteoblasts from the adjacent fracture fragments can migrate and form new bone through stimulation with local factors. Commonly available materials include ceramics such as various forms of calcium phosphate, bioglasses or highly processed allogeneic or xenogeneic bone matrix(66, 67). Osteoinductive grafts provide additional factors, such as the clinically available BMP-2 and BMP-7, which further stimulate bone formation when applied in supraphysiological doses. A stringent requirement for osteoinductive grafts is that they can produce bone upon implantation in an ectopic site without any fracture nearby(66, 68). Finally osteogenic grafts contain both factors and osteoblasts which are directly able to generate bone. Apart from the transplantation of actual bone fragments as detailed above, off-the-shelf osteogenic grafts are an active area of development and still far from regular clinical application.  
Although for osteoconductive and osteoinductive grafts there exist commercially available materials(68) (Table 1), they all suffer from significant drawbacks. Osteoconductive materials in general require an othewise healthy environment, since they depend completely on the host signals and cells. They are also limited in size and may form non-unions. Currently available osteoinductive materials either raise concerns because of the supraphysiological use of signaling molecules such as BMP or are generally difficult to produce and standardize, as in the case of demineralized bone matrix(66).  
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Table 1: Commercially available osteoinductive bone substitutes. One product per company is listed. DBM = Demineralized Bone Matrix. BMP = Bone Morphogenic Protein. US FDA = United States Food and Drug Administration. EU = European Union. Adapted from Miron et al.(68) and Liu et al.(67) 
Tissue Engineering of Bone The development of bone substitutes in general and osteogenic grafts in particular is a form of tissue engineering. Classically, this includes the selection of appropriate bone 
 ~ 15 ~  
forming cells, a supportive scaffold, appropriate culture conditions, some form of quality control and the testing of grafts in an animal model. 
Cell Source Osteoblasts, osteocytes and osteoclasts involved in normal bone formation and homeostasis are terminally differentiated cells which are very difficult to cultivate in vitro and are therefore not used directly. Instead, progenitors or even stem cell are used because of their better availability, easier cultivation and plasticity.  
For differentiation of osteoblasts and osteocytes, the discovery of the adult mesenchymal stromal cell (MSC) in bone marrow has been a major mile stone(69, 70). Although currently induced pluripotent stem cells(71) and embryonic stem cells(72) are also being used for bone generation, adult MSC offer many advantages. They can be applied autologously, are relatively easy to isolate and expand(73) and have found approval for clinical trials(74). A minimal set of criteria for the identification of MSC has been proposed(75): 
1. Adherence to plastic when maintained in standard culture conditions.  2. Expression of  CD105, CD73 and CD90; no expression of CD45, CD34, CD14 or CD11b, CD79α or CD19 and HLA-DR on the surface 3. Differentiation to osteoblasts, adipocytes and chondroblasts in vitro. 
Sources such as muscle, fat or synovium have also been proposed for adult MSC, with subtle differences in differentiation kinetics(76, 77).  In some cases genetic modification of these cells has been performed to add production of osteoinductive factors such as BMPs(78). 
CD14-positive monocytes from peripheral human blood are precursors for both osteoclasts and macrophages(38, 39). They can be easily collected, purified and 
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immediately stimulated with RANKL and M-CSF(40) to yield multinucleated osteoclasts, which are fully functional(79, 80).  
An intriguing source of several cell populations is the stromal vascular fraction(SVF) of adult human fat tissue(81) (Figure 6). The contained MSC, monocytes and endothelial cells could have the potential to differentiate into osteoblasts, osteoclasts and capillaries in a suitable environment.  
 
Figure 6: SVF cells as a viable source of MSC, endothelial cells and monocytes, which can become osteoblasts, capillaries and osteoclasts respectively. 
Scaffold Material Most commonly, MSC are seeded and differentiated on suitable biomaterials mimicking in their composition, porosity and biomechanics the physiological bone(82).  This biomimicry has been achieved trough the use of ceramics, polymers of natural (e.g. collagen) or synthetic origin, bioglasses or composites (67, 82). The biomaterials should support  the adhesion, proliferation and differentiation of cells(67, 73). As a consequence of their use as implantable devices they should also be biocompatible and biodegradable(67), ensuring that no overwhelming inflammation or toxicity arises and complete bone regeneration occurs. Addition of metal ions as a means of improving both 
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biomechanics and osteoinductive properties of the scaffolds has been investigated(67).  For better invasion of host vasculature after implantation, pore sizes of 150-500um and interconnected geometries have been proposed(67). However, the role of pore size in osteogenicity is not well understood and manufacturing of standardized architectures can be challenging(83). In hydrogel systems the addition of peptides and signaling molecules has been used to improve osteoinductivity (84, 85). Most commonly, calcium phosphate in one or several crystalline structures such as hydroxyapatite, bicalcium phosphate or tricalcium phosphate is used(86).  
Culture Conditions To use a cell-seeded biomaterial as an actual osteogenic graft, in vitro culture allowing the differentiation of cells and tissue formation may be necessary. However, a valid consideration for clinical application is the regulatory complexity when dealing with extensive pre-differentiation as opposed to a direct use of cells(87). Therefore, a variety of culture protocols have been used, ranging from intraoperative seeding and implantation to extensive in vitro culture in a dedicated bioreactor system. 
Intraoperative application of cells either in isolation (88, 89) or mixed with scaffold materials and osteoinductive peptides(90) have been investigated. Additionally, the approach of ectopic implantation as an in vivo « bioreactor » has been developed, in which the graft would develop both bone and vasculature before final orthotopic transfer (91-94). As a drawback, these strategies depend on vascularization by the host and are not well controlled in terms of homogenous bone formation.  
In vitro culture allows the targeted modification of the graft to manufacture homogenous and functional tissue. It is important to control basic parameters such as oxygen supply (95-98), culture medium pH(99) and waste removal. As described above, stimulation with several signaling molecules may be necessary to differentiate MSC into osteoblasts, for example by exposure to Wnt, Hedgehog, Nell1, BMP or IGF(100). 
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Mechanical stimulation of the osteogenic pathway using fluid shear stress could be benefitial(101). In addition, culture of 3D volumes as opposed to flat sheets of cells increases the complexity and poses the problem of mass transfer. 
 
Figure 7: Possibilities of in vitro culture. 
3D cultures with controlled parameters may be best achieved with the use of dedicated bioreactors (83, 102) (Figure 7). They can guarantee homogenous cell distribution during seeding and a homogenous supply of nutrients, oxygen and signaling molecules as well as application of shear stresses (83, 102). Improved in vivo bone formation after seeding and pre-culture using these systems has been reported(102-106).  
Quality Control For clinical applications, quality control will be necesssary during graft production (83, 102). Invasive monitoring is desctructive and tissue biopsies may not be representative, whereas tissue replicates may be misleading because of residual variability.  The non-invasive monitoring of actual tissue formation could address these issues, yet it is still very challenging both in standard cultures and in bioreactors. Monitoring of glycosaminoglycan or collagen content in supernatants using high resolution nuclear magnetic resonance (NMR) as well as monitoring of the differentiation status of MSC using high resolution imaging have been proposed(107) but are expensive and 
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technically demanding. In addition, the relevance of these parameters has to be proven for specific culture systems and tissue types. 
Animal Models Models of ectopic bone formation are an important testing ground for bone substitute materials(68). Implantations have been performed in skeletal muscle, kidney capsule and also subcutaneously(87). Both skeletal muscle and the kidney capsule offer immediate blood supply and the presence host MSC, making them less suitable as models of clinical bone regeneration(87). Subcutaneous implantations represent a much more challenging environment and are used most frequently. 
To go forward in clinical translation it is necessary to develop various orthotopic models in large animals(102, 108, 109). These models may include calvarial or iliacal round defects without any load bearing as well as segmental defects of the long bones with varying degrees of load. As an option before going into expensive large animal trials with sheep, goats or pigs(110-112), rabbit models can be used as a cost-effective alternative(109) with a clinically relevant size(113). The use of species-specific cells may be required since the animals are immunocompetent and immunosuppression may interfere significantly with inflammatory pathways important for fracture healing. 
Developmental Engineering All of the above presented strategies for the creation of osteogenic grafts rely on the close resemblance of materials and cells to normal bone. MSC differentiation directly into osteoblasts has been described as a corner stone of osteoinductivity and osteogenicity(68). The grafts thus follow the process of intramembraneous ossification and require immediate vascularization (91, 113-115) after implantation. The resulting bone is highly dependent on the chosen differentiation pathways(100) and culture conditions(83).  
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A novel approach, developmental egnineering aims to design a process which mimics the embryological development of a given tissue(116). The principle is that stem cells can replicate a developmental program given the right trigger without relying on further external cues(116). This approach offers several advantages : it is robust and stable, multiple stages allow observation and quality control, every stage of tissue formation is only dependent on the previous stage and the tissue is self-organized(116). Endochondral ossification is a prime example of such a process(116), especially because all stages of the tissue can be present at the same time and regulate each other through the IHH/PTHrP feedback loop, as described above. In addition to robust tissue formation, the signaling allows several smaller modules of tissue to self-organize into larger entities (116, 117). However, to be even more biomimetic, co-cultures with different other cell types may be required(116).  
The described principles have lead to the development of engineered hypertrophic cartilage as a bone substitute (118-122), which displays advantageous properties such as resistance to hypoxia (122-124) and gradual vascular invasion(125). This type of graft has been used in orthotopic models such as calvarial(126) or femoral segmental defects (127, 128) and with strategies as diverse as monolithic constructs (125, 126, 128), pellets between 1-3mm  in diameter (127, 129) or complex modified structures (125, 130). Generation of greater tissue volumes has been proposed using bioreactor systems(131, 132). As a next biomimetic step, co-cultures of hypertrophic cartilage with endothelial cells have been performed to improve mineralization(133). For clinical applications of engineered hypertrophic cartilage, a remaining drawback is the use of autologous MSC to form the graft. Although necessary to prevent immunologic rejection, autologous MSC use means additional extraction and a significant time-delay. The interdonor variability encountered with MSC (127, 134) may also lead to unpredictable outcomes.  
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Devitalization of Tissues The use of allogeneic hypertrophic cartilage of high quality would be possible if immunologic rejection could be prevented. This could be achieved through removal of cells, since matrix constituents are hihgly conserved and may even prevent an adaptive immune response(135). Indeed, the extracellular matrix itself may hold sufficient cues to instruct cell function and identity(136). Moreover, in the case of hypertrophic cartilage, apoptosis of hypertrophic chondrocytes(7) and the release of matrix bound signals such as VEGF through MMP-mediated matrix degradation(21) are part of the natural developmental and growth processes. Thus devitalization of allogeneic hypertrophic cartilage by chemical or physical means or induction of apoptosis(137) can be an alternative to the use of patient derived grafts. Yet, even though devitalized hypertrophic cartilage may form complete bone organs(138), it seems to be remodeled much slower than the living matrix(130, 139). 
Re-activation of Devitalized Matrix To improve the remodeling efficiency of devitalized matrix, an additional step before implantation may be necessary. Following the natural process of endochondral ossification detailed above, diverse cell types such as endothelial cells, osteoclasts, macrophages and mesenchymal stem cells need to be present during the late stages of matrix remodeling. In terms of developmental engineering, the addition of a subsequent module(117) through co-culture with the appropriate cell types(116) could be required. As mentioned above, peripheral blood can be used to derive osteoclasts and the stromal vascular fraction of fat is a rich source of MSC and endothelial progenitors. This opens the possibility of « re-activating » the devitalized hypertrophic cartilage intraoperatively before implantation. Using this approach would allow the generation of an off-the-shelf product, which could be used in a defined procedure as a bone substitute for various applications (Figure 8). 
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Figure 8: Devitalized hypertrophic cartilage as an off-the-shelf	  material,	  which	  is	  “re-activated”	  before	  use. 
 
 
General Aim of the Thesis Based on the introduced concepts of endochondral ossification, developmental engineering, devitalization and reactivation, the aim of my thesis is to validate possible applications of engineered hypertrophic cartilage. Two main pathways could lead to a rapid clinical translation (Figure 9). First, the engineering of hypertrophic cartilage by autologous bone marrow derived mesenchymal stromal cells could be directly used. This requires suitable production methods for large graft generation and a way of monitoring and assuring the quality of resulting grafts. Second, engineered hypertrophic grafts could be pre-produced of from allogeneic sources, subsequently devitalized and re-activated with different cell types.  
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Figure 9: Two pathways for the use of engineered hypertrophic cartilage as a bone substitute. 
 
Specific Aims of the Chapters The scientific work is presented in the form of four scientific publications. 
Chapter 2 « Monitoring perfusion-based bioreactor cultures of engineered 
hypertrophic cartilage towards clinically oriented production of bone 
grafts » This chapter deals with the generation of hypertrophic cartilage in a perfusion bioreactor system, monitoring of culture parameters and the correlation of monitoring parameters and in vivo bone formation. The hypothesis is that glycosaminoglycan and alkaline phosphatase content in culture supernatants are relevant for endochondral ossification and therefore correlate with tissue integrity and maturity. Rabbit bone marrow derived mesenchymal stem cells are used in order to generate protocols and guidelines for a future pre-clinical trial in a rabbit orthotopic model.  
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Chapter 3 « Osteoinductivity of engineered cartilaginous templates 
devitalized by inducible apoptosis » This chapter aims to characterize the effect of different modes of devitalization on the engineered hypertrophic matrix. The hypothesis is that a soft devitalization method better preserves growth factors and components of the extracellular matrix and consequently enhances osteoinductivity compared to a harsh method. Morphological appearance, content of specific morphogens and ultimately, bone formation capacity in vivo are analyzed(140).  
Chapter 4 « Interaction of CD14+ monocytes and engineered hypertrophic 
cartilage during end-stage endochondral ossification » This chapter investigates the interaction of living and devitalized hypertrophic cartilage with peripheral blood derived monocytes. The hypothesis is that primed osteoclastogenic monocytes seeded in vitro on the hypertrophic matrix can degrade the tissue, release chemoattractant factors and ultimately improve bone formation. In vitro, the formation of osteoclasts, the secretion of factors in supernatants, the attraction of monocytes, endothelial cells or mesenchymal stem cells and the differentiation of mesenchymal stem cells in the presence of secreted factors are analyzed. In vivo, the presence of osteoclasts, macrophages, endothelial cells and mesenchymal stem cells is described at an early time point, as well as the bone formation at a late time point.  
Chapter 5 « Fat-derived stromal vascular fraction cells enhance the bone 
forming capacity of devitalized engineered hypertrophic cartilage matrix » This chapter explores the regenerative potential of devitalized hypertrophic cartilage re-activated by stromal vascular fraction (SVF) cells from human adipose tissue. The hypothesis is that the presence of multiple progenitor lineages in the SVF can enhance bone formation. Multiple pellets of devitalized matrix are combined together with different amounts of SVF and implanted subcutaneously. The contribution of SVF to 
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the bone formation, vascularization and bone resorption are analyzed. The system is then tested in an orthotopic model in the rat calvarium.  
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Abstract(
In! vitro! engineered! hypertrophic! cartilage! is! a! promising! bone! substitute! material.! However,!
tissue!with! a! thickness! of!more! than! 3mm! can! develop! central! core! necrosis! due! to! limited!mass!
transport! during! culture.! To! address! this! issue,! perfusionEbased! bioreactors! have! been! used,! yet!
effective!monitoring!and!predictive!parameters! for! tissue! formation!and! in! vivo!performance!have!
not!been! investigated! in!detail.! In! this! study!we!cultured!6x3mm!hypertrophic! cartilage! constructs!
derived!from!rabbit!bone!marrow!mesenchymal!stromal!cells! in!a!perfusion!bioreactor.!Monitoring!
of! glycosaminoglycans! (GAG)! and! alkaline! phosphatase! (ALP)! in! the! supernatants! was! performed!
during!3!weeks!of! chondrogenesis!and!2!weeks!of!hypertrophy.!Tissues!with! typical!morphological!
and!molecular!traits!of!hypertrophic!cartilage!formed!after!a!total!of!5!weeks!bioreactor!culture.!GAG!
and!ALP!in!supernatants!positively!correlated!with!GAG!accumulated!in!the!matrix.!In!some!cultures!
nonEhomogenous!tissue! formed,!possibly!due!to!metalloproteinaseEmediated!cartilage!digestion!by!
residual! CD45+! cells.! The! levels! of! released! GAG! correlated! significantly! with! the! percentage! of!
cartilaginous!matrix! in!these!tissues.!After! implantation!in!nude!mice!for!up!to!12!weeks,!bone!and!
bone!marrow!formed!by!endochondral!ossification.!Total!bone!volume!correlated!significantly!with!
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the!levels!of!GAG!and!ALP!quantified!in!the!supernatants.!The!findings!indicate!that!quantification!of!
GAG! and! ALP! released! during! the! bioreactorEbased! culture! enable! to! monitor! the! quality! of! the!
hypertrophic!cartilage!developing!and!inform!on!its!osteogenic!capacity!in!vivo.!Such!measurements!
can!thus!be!used!as!nonEinvasive,!inEprocess!quality!control!for!bone!grafts.!!!
Introduction(
Since! the! demonstration! that! hypertrophic! cartilage! can! be! engineered! in! vitro! from! bone!
marrow!mesenchymal!stromal!cells!and!undergoes!a!process!related!to!endochondral!ossification!in!
vivo(1E4),! the! field!of! regenerative!medicine!has! rushed! to!prove! the! regenerative!potential!of! this!
material! and!promote! its! clinical! application.! So! far! this! has! included! implantation!of! hypertrophic!
cartilage!in!orthotopic!models!such!as!calvarial(5)!or!femoral!segmental!defects(6,!7)!and!strategies!
as!diverse!as!monolithic!constructs(5,!7,!8),!pellets!between!1E3mm! in!diameter(6,!9)!and!complex!
modified!structures(8,!10).!The!homogenous!tissue!generation!in!constructs!with!3mm!thickness!has!
been!challenging!in!static!culture!and!unidirectional!perfusion(11,!12).!Although!the!use!of!perfusion!
bioreactors(13,! 14)! has! been! shown! as! a! viable! way! to! improve! and! upscale! production! of!
hypertrophic! cartilage(12),! the! effects! of! perfusion! on! construct! generation! have! been!
controversial(15).!
According! to! Lourenco! et! al.(16),! “RealEtime!monitoring! of! bioreactors! is! now! regarded! as! an!
essential!part!of!effective!bioprocess!control!that!can!lead!to!increased!efficiency,!productivity,!and!
reproducibility!and!also!to!improved!quality!control![...],!thus!optimizing!overall!costs”.!Furthermore,!
as!Gardel!et!al.(17)!put!it!in!the!context!of!cartilage!tissue!engineering,!“[...]an!advantage!in!the!area!
would!be!the!development!and!employment!of! techniques,!which!could!assess! the! integrity!of! the!
tissue!noninvasively.“!
Following! this! reasoning! we! have! strived! to! identify! relevant! parameters! for! an! atElineE
monitoring! during! the! generation! of! hypetrophic! cartilage! in! perfusion! bioreactors.! Although!
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monitoring!of!ECM!components!such!as!glycosaminoglycans!(GAG)!or!collagens!using!high!resolution!
NMR!as!well!as!monitoring!of! the!differentiation!status!of!MSC!using!high!resolution! imaging!have!
been!proposed(18),!most!propositions!would!require!very!expensive!machinery!to!be!implemented.!
Monitoring!of!alkaline!phosphatase!activity!in!supernatants!from!osteogenically!differentiating!bone!
marrow! mesenchymal! stromal! cells! in! bioreactors! has! been! performed(17),! but! not! extensively!
correlated!to!tissue!formation!in!vitro!or!in!vivo.!Since!the!culture!of!hypertrophic!cartilage!involves!
chondrogenesis!and! results! in! later!bone! formation,!we!decided! to!monitor!both!GAG!and!alkaline!
phosphatase!(AP)!activity!using!relatively!simple!and!fast!biochemical!methods.!!
Our! hypothesis! was! that! we! could! closely! monitor! in! vitro! tissue! formation! by! tracking! both!
parameters.!More! importantly,!we!hypothesized! that! the! level!of! the!parameters!would! inform!on!
the!tissue!maturity!and!thus!also!predict!in!vivo!bone!formation.!!!
For! the! construct! generation! in! this! present! study,! we! employed! rabbit! bone! marrow!
mesenchymal! stromal! cells.! After! mouse! and! rat! models,! a! rabbit! calvarial! or! segmental! defect!
model(19)!would!be!an!expected!next!step!for!clinical!translation.!Thus!the!data!resulting!from!this!
present!study!would!be!highly!useful!for!future!preEclinical!trials.!
Materials(and(Methods(
Isolation(and(culture(of(rabbit(BMSC(
All!rabbit!procedures!were!reviewed!and!approved!by!the!Swiss!Federal!Veterinary!Office!(Permit!
BS! 2080).! Bone! marrow! was! extracted! from! the! right! iliac! crest! of! 7! female! New! Zealand!White!
Rabbits!(NZW,!Charles!River!Laboratories,!Kisslegg,!Germany)!between!8!and!10!weeks!of!age.!Before!
the!procedure!animals!were!anesthetized!with!25mg/kg!Ketamin!and!2.5!mg!/!kg!Xylazin!(Veterinaria!
AG,!Zürich,!Switzerland)!by!subcutaneous!injection.!Anaesthesia!during!the!procedure!was!continued!
with! Isoflurane!2.5%! in!1l!/!min!O2.!Buprenorphin!0.05mg/kg! (Temgesic,!Essex!Chemie!AG,!Luzern,!
Switzerland)!was!given!for!analgesia!during!the!operation!and!reEadministered!2E3!times!daily!for!the!
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first!2!weeks.!The!area!over!the!right!illiac!crest!was!shaved,!disinfected!with!Octenisept!(Schülke!&!
Mayr!AG,!Switzerland)!and!a!stab!incision!to!the!bone!was!performed.!A!bone!marrow!biopsy!needle!
for! children! (Jamshidi,! CareFusion,! Kelberg,! Germany)! was! used! and! up! to! 6ml! of! bone! marrow!
aspirated!with!a!10ml! syringe! filled!with!1!ml!heparin! solution! (HeparinENa!5000! IU! /!ml,!B.!Braun!
Medical!AG,!Emmenbrücke,!Switzerland).!The!wound!was!closed!with!a!single!stitch!suture!(Prolene!
5/0,!Ethicon,!Somerville,!NJ,!USA)!and!the!animals!allowed!to!recover!under!infrared!light.!!
Nucleated!cells!in!the!bone!marrow!aspirates!were!counted!and!100‘000!cells!/cm2!were!seeded!
on!tissue!culture!flasks!with!complete!medium!(alphaEMEM,!10%!fetal!bovine!serum,!1%!penicillinE
streptomycinEglutamate,! 10! mM! HEPES,! 1mM! sodium! pyruvate,! all! from! Gibco,! Invitrogen,! Basel,!
Switzerland)! and! 5! ng/ml! FGFE2! (R&D! Systems,!Wiesbaden,! Germany).! After! reaching! confluency,!
cells!were!washed!with!PBS,!detached!with!0.5!mg/ml!trypsin!(Gibco,!Basel,!Switzerland)!and!frozen!
in!90%!FBS!and!10%!DMSO.!Before!use!in!a!bioreactor,!3000!cells!/cm2!were!seeded!with!complete!
medium!and!5!ng/ml!FGFE2!and!expanded!until!passage!three.!!
Bioreactor(culture(
The!oscillatory!perfusion!bioreactor!system!described!by!Wendt!et!al(13)!was!used!for!this!study.!
Collagen! type! I! based! scaffolds! (Ultrafoam,! Davol! Inc.,! USA)! were! soaked! in! phosphate! butter!
solution! (PBS)! for! at! least! 20! minutes! and! cylinders! of! 8! mm! diameter! and! 3! mm! height! were!
punched!out.!The!scaffolds!were!placed!on!a!plastic!grid!and!clamped!using!a!1!mm!wide!teflon!ring!
with!an!inner!diameter!of!6!mm,!ensuring!perfusion!of!a!6!x!3!mm!volume!of!scaffold.!As!published!
previously(11,! 12),! 2.5! E! 3! million! cells! per! scaffold! were! seeded! using! chondrogenic! medium!
consisting!of!!serum!free!medium!(DMEM,!1.25!mg/ml!human!serum!albumin,!10!mM!HEPES,!1!mM!
sodium!pyruvate,!1%!penicillinEstreptomycinEglutamate!and!1%!ITSE1,!all!from!Gibco,!Switzerland),!10!
ng/ml! TGFβ3! (Novartis,! Basel,! Switzerland),! 10E7! M! dexamethasone! and! 0.1! mM! ascorbateE2E
phosphate! (both! from!Sigma!Aldrich).!Seeding!was!performed!using!a!perfusion!speed!of!3!ml/min!
overnight,! while! 0.! 3ml/min! were! used! for! subsequent! culture.! Static! culture! was! performed! as!
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described!previously(11).!Briefly,!6!x!3!mm!scaffolds!were!manually!seeded!with!3!million!cells!in!60!
µl!chondrogenic!medium!and!cultured!in!agarose!coated!plates!with!1!ml!medium.!Medium!changes!
were!performed!manually!twice!per!week.!After!21!days,!hypertrophic!medium!consisting!of!serum!
free!medium,!0.05!µM!LEthyroxin,!10E6!M!dexamethasone,!10!mM!βEglycerophosphate!and!0.1!mM!
ascorbateE2Ephosphate! was! used! instead! of! chondrogenic! medium! for! additional! 14! days.! For!
metalloproteinase! inhibition,! 15! nM!Merimastat! (Sigma! Aldrich)! was! added! to! the! culture! media!
both!during!chondrogenesis!and!hypertrophy.!
Monitoring(of(GAG(and(ALP(
Supernatants!of!each!medium!change!were!analysed!for!glycosaminoglycan!content!and!alkaline!
phosphatase! activity.! ! For!GAG,! the!method! of! Barbosa! et! al(20)!was! employed.! Briefly,! 250!µl! of!
supernatant! were! incubated! with! approximately! 1! ml! of! DMMB! solution! (16! mg/l! DMMB,! 6! mM!
sodium! formate,!200!mM!GuHCL,! all! from!Sigma!Aldrich)!on!a! shaker!at! room! temperature! for!30!
minutes.! Precipitated! DMMBEGAG! complexes! were! centrifuged! and! supernatants! were! discarded.!
Complexes!were!dissolved!in!decomplexion!solution!(4!M!GuHCL,!50!mM!NaEAcetate,!10%!PropanE1E
ol,! all! from! Sigma! Aldrich),! absorption! was! measured! at! 656! nm! and! GAG! concentrations! were!
calculated!using!a!standard!curve.!
For!ALP,!the!method!of!Burstone(21)!with!adaptations!was!employed.!Briefly,!50!µl!supernatant!
was! incubated!with! 50!µl! buffer! (5!mg/ml! pEnitroEphenyl! phosphate,! 200!mM! TRIS,! 1!mM!MgCl2,!
pH9.5)! at! 37°C! in! triplicate.! Adding! 50! µl! of! 1! M! NaOH! stopped! the! reaction,! absorption! was!
measured!at!405!nm!and!ALP!activity!was!calculated!using!a!standard!curve.!
GAG(and(DNA(content((
For!measurements! of! the!GAG! and!DNA! accumulated! in! the!matrix! at! the! end! of! the! culture,!
samples!were!digested!overnight!with!Proteinase!K!solution!(1!mg/ml!Proteinase!K!in!50!mM!Tris!pH!
7.6,! 1! mM! EDTA,! 1! mM! Iodoacetamide,! 10! µg/ml! Pepstatin,! all! from! Sigma! Aldrich).! GAG!
measurements!were!performed!as!described!above.!DNA!measurements!were!performed!with! the!
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CyQuant! kit! (Thermo! Fisher! Scientific,! Zug,! Switzerland)! according! to! the! protocol! of! the!
manufacturer.!
Implantations(
All!mouse!procedures!were! reviewed!and!approved!by! the!Swiss! Federal!Veterinary!Office! (BS!
1797).!Female!nude!mice!6!E!8!weeks!of!age!were!anesthetized!using! isoflurane!2%!in!1! l!/!min!O2.!
The!skin!on! the!back!was!disinfected!and!cut!along! the!midline! for!maximally!8mm.!Subcutaneous!
pockets!were!prepared!on!both!sides!by!blunt!dissection!and!samples!were! inserted.!The!skin!was!
closed! with! surgical! staples! and! the! mice! were! allowed! to! recover! under! red! light.! They! were!
subsequently!kept!according!to!the!animal!husbandry!guidelines!of!the!University!Hospital!Basel,!had!
free! access! to! food! and! water! and! were! regularly! checked! for! signs! of! pain,! infection! or! wound!
opening.!Staples!were!removed!after!7!E!10!days.!After!8!or!12!weeks,!mice!were!euthanized!using!
CO2! in! a! dedicated! chamber! and! the! implants! removed! and! stored! immediately! in! 1.5%! PFA! for!
further!processing.!!Several!femurs!were!extracted!for!additional!microtomographic!measurements.!
Microtomography(
Microtomography!was! performed! using! a! tungsten! xEray! source! at! 70! kV! and! 260!µA!with! an!
aluminium! filter! of! 0.5!mm! (Nanotome,!GE).! Transmission! images!were! acquired! for! 360°!with! an!
incremental! step! size!of!0.25°.! !Volumes!were! reconstructed!using!a!modified!Feldkamp!algorithm!
(software!supplied!by!manufacturer)!at!a!voxel!size!of!2.5!–!3!µm.!Thresholding,!segmentation!and!
3D! measurements! were! performed! using! the! Image(22)J! software! with! the! BoneJ(23)! and! 3D!
Shape(24)!additions.!
Histology(
Samples!were!embedded!in!paraffin!and!sections!of!5!μm!thickness!prepared!using!a!microtome.!
SafraninEO,! Alizarin! red,! hematoxylin/eosin! and! Masson! triEchrome! staining! were! performed! as!
published! previously(11).! Quantification! of! cartilaginous! area! percentage! was! performed! on! 4!
representative! SafraninEO! stained! sections! per! sample.! Primary! antibodies! for! CD45! (MCA808GA,!
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AbD!Serotec),!DIPEN!(1042002,!MDBiosciences,!USA),!collagen!type!II!(ab34712),!collagen!type!X!
(ab49945),!MMPE9!(ab38898)!and!MMPE13!(ab39012,!Abcam,!UK)!were!used.!After!washing!and!
incubation!with!an!appropriate!biotinylated!secondary!antibody!(Dako,!Denmark),!the!stainings!were!
developed!with! the!Vectastain!ABC!kit! (Vector! Laboratories,!USA)! according! to! the!manufacturer’s!
protocols.!!
Statistical(Analysis(
Data! was! analysed! by! tEtest,! ANOVA! and! Pearson! correlation! using! the! GraphPad! Prism! v2.2!
software.! A! significance! level! alpha! of! 0.05! was! set.! Average! values! and! standard! deviations! are!
reported.!
Results(
Generation( of( hypertrophic( cartilaginous( matrix( in( a( 3D( perfusion(
bioreactor(system(
Measurement! of! GAG! content! and! ALP! activity! in! supernatants! was! feasible! at! each!medium!
change! and! resulted! in! curves! of! a! characteristic! shape! (Figure! 1A! and!B).!Medium! from! replicate!
bioreactor! cultures! showed! some! variability,! mostly! in! ALP! activity.! The! highest! values! for! each!
measurement!were!observed!at!the!second!medium!change!after!7!days!of!culture.!!GAG!content!in!
the! tissues! as! well! as! GAG/DNA! ratio! positively! correlated!with! the! GAG! and! ALP!measurements,!
though!only!the!correlation!of!GAG/DNA!with!GAG!in!supernatants!reached!statistical!significance!(r!
=! 0.96,! p! =! 0.04,! Figure! 1C).! For! subsequent! in! vitro! cultures,! only!GAG!was! used! to! assess! tissue!
formation.!
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Figure' 1:! Generation! of! hypertrophic! cartilagineous! matrix! in! a! 3D! perfusion! system.! Donor! R11.! A:! Cumulative! secretion! of!
glycosaminoglycans!in!supernatants!of!perfusion!culture.!B:!Cumulative!ALP!activity!in!supernatants!of!perfusion!culture.!C:!Correlation!of!
secreted!GAG!and!GAG!/!DNA!ratio!of!the!matrix.!r!=!0.96,!P!=!0.04.!D:!SafraninEO!staining!of!5!weeks!static!culture!displaying!typical!central!
necrosis.!Black!bar!represents!200!μm.!G:!Formation!of!preEhypertrophic!matrix!after!3!weeks!of!culture.!CII!=!collagen!type!2!staining,!CX!=!
collagen! type! X! staining.! The! peripheral! presence! of! collagen! type! X! suggests! that! the! matrix! is! becoming! hypertrophic.! Black! bar!
represents!500!μm.!H:!Hypertrophic!matrix!after!5!weeks!of!culture.!Alizarin!red!staining!shows!peripheral!calcification.!Collagen!type!X!
staining!is!present!throughout!the!matrix.!Black!bar!represents!500μm.!!
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The!presence!of!central!core!necrosis!was!confirmed! in!static!cultures!of!the!same!volume!and!
cell! number! (Figure! 1D).! Histological! analysis! of! perfusion! cultures! showed! homogenous! tissue!
formation!without!central!core!necrosis!or!fibrosis!both!in!the!chondrogenic!and!hypertrophic!phases!
(Figure!G! and!H).! Already! during! the! chondrogenic! phase,! deposition! of! both! collagen! type! II! and!
collagen! type!X! could!be!observed,! suggesting! that! the! tissue!already! acquired!hypertrophic! traits.!
However,!collagen!type!X!was!only!found!in!the!periphery!of!the!constructs.!After!the!hypertrophic!
phase,!collagen!type!X!was!homogenously!distributed!and!a!calcified!outer!part!was!observed!with!
Alizarin!red!staining.!Even!though!the!samples!displayed!dense!matrix!and!calcification,!perfusion!did!
not!seem!to!be!affected!during!bioreactor!culture.!
Monitoring(in(non.homogenous(cultures(
Cultures!with!unsatisfactory!secretion!of!GAG!were!stopped!at!different! time!points! to!analyse!
the!formation!of!cartilaginous!tissue!(Figure!2A).!The!tissues!in!these!cultures!were!found!to!be!nonE
homogenous! and! the! relative! area! of! SafraninEO! positive! cartilaginous! matrix! was! significantly!
correlated! with! the! amount! of! GAG! secretion! (P! =! 0.04,! Figure! 2B! and! C).! The! nonEhomogenous!
tissue!formation!was!connected!to!CD45!positive!cells!E!possibly!bone!marrowEderived!macrophages!
E!which!were!present!even!after!3!passages!on!2D!plastic!(Figure!2D).!!The!number!of!CD45!positive!
cells!was!at!least!2Efold!higher!in!cultures!where!nonEhomogenous!tissue!had!formed!as!opposed!to!
cultures!where!homogenous!tissue!had!formed!(P!<!0.01,!Figure!2E).!Indeed,!histological!analysis!of!
nonEhomogenous! tissue! also! revealed! the! presence! of! CD45! positive! cells,! as! opposed! to! their!
complete!absence!in!homogenous!tissue!(data!not!shown).!!
!~"43"~"
!
!
Figure' 2:!Monitoring! in! nonEhomogenous! cultures.! A:! Representative! GAG! secretion! for! each! donor,! labelled! AEF.! ! Cultures!were!
stopped! at! different! times! to! evaluate! cartilagineous! matrix! formation.! B:! Correlation! of! GAG! secretion! at! 10! days! an! percenteage!
cartilaginous!matrix.!Each!dot!represents!one!donor.!C:!Representative!SafraninEO!stainings!for!each!donor!tested.!The!black!bars!represent!
200μm!in!A,!100μm!in!C,!200μm!in!E,!200μm!in!F.!D:!Representative!CD45!staining!in!a!confluent!rabbit!BMSC!culture!at!!passage!3.!Black!
bar!represents!50μm.!E:!Quantification!of!CD45!positive!cells!in!confluent!cultures!of!rabbit!BMSC!donors.!Average!of!10!highEpower!fields!
(HPF,!40x!magnification)!for!each!donor.!(**=P<0.01)!!
In(vivo(remodeling(of(hypertrophic(cartilage(from(perfusion(bioreactor(
cultures(with(best(parameters(
!Implantation! of! hypertrophic! cartilage! with! the! best! in! vitro! monitoring! parameters! lead! to!
modest!bone!and!bone!marrow!formation!already!after!8!weeks! (Figure!3A).!Large!portions!of! the!
cartilaginous!matrix!were!still!present,!even!though!they!were!no!longer!positive!for!GAG,!suggesting!
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an! onEgoing! digestion! and! remodelling! process.! Indeed,! staining! for! DIPEN,! the! cryptic! epitope! of!
aggrecan,!which!is!exposed!during!cartilage!remodelling,!showed!active!areas!of!matrix!breakdown.!
The!same!areas!were!also!positive! for!MMPE9!and!MMPE13,!which!are!active!during!endochondral!
ossification.!
After!12!weeks!in!vivo,!the!hypertrophic!cartilage!had!nearly!disappeared!and!been!replaced!by!a!
vast!bone!marrow!cavity,!a!thin!surrounding!bone!lamina!and!few!trabecular!structures!and!calcified!
remnants! of! cartilage! (Figure! 3B).! Again! DIPEN! staining! displayed! areas! of! ongoing! cartilage!
degradation,!which!were!however!considerably!reduced!compared!to!8!weeks.!MMPE9!staining!was!
much!weaker!and!no!MMPE13!staining!was!detected!at!this!time!point.!!
Microtomographic!analysis!also!showed!a!significantly!increased!amount!of!bone!after!12!weeks!
compared!to!8!weeks! (p!=!0.05,!Figure!3C).!Due!to!the!high!resolution!and!tissue!geometry,! it!was!
possible!to!separate!bone!lamina,!calcified!hypertrophic!cartilage!remnants!and!bone!marrow!cavity!
(Figure!3D).!A!comparison!with!normal!mouse! femurs!showed!that!although!bone!volume!by! itself!
was! modest,! bone! marrow! volume! was! comparable! to! the! bone! marrow! volume! of! the! femur!
diaphysis!(Figure!3E).''
Figure'3:! In!vivo!remodeling!of!hypertrophic!cartilage!from!perfusion!cultures!with!best!parameters.!Donor!R11.!A:!Representative!
histological!sections!after!8!weeks!in!vivo.!Large!remaining!volume!of!cartilagineous!tissue!depleeted!of!glycosaminoglycans!is!visible.!HE!=!
Haematoxylin!&!Eosin,! SafEO!=!SafraninEO! staining,!Masson!=!Masson! triEchrome!staining,!DIPEN!=! cryptic!epitope!of!aggrecan! staining.!
Black! bars! represent! 500μm.! B:! Representative! histological! sections! after! 12!weeks! in! vivo.! Thin! bone! lamina! and! some! cartilagineous!
remnants!surround!large!bone!marrow!space.!C:!Bone!volume!measured!by!microtomography!after!8!and!12!weeks!in!vivo.!(*=P<0.05)!D:!
Microtomographical! reconstruction!displaying!threshold! for!bone!volume.!Red!pixels!were!counted!as!bone,!grey!and!white!pixels!were!
counted! as! calcified! cartilagineous! remnants,! black! pixels! enclosed! in! the! convex! volume! defined! by! red! pixels! were! counted! as! bone!
marrow.!E:!Bone!volume!(BV),!bone!marrow!volume!(BMV),!residual!volume!(RV)!compared!to!the!bone!volume!and!bone!marrow!volume!
(diaphysis!only)!of!a!normal!mouse!femur.!
!
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Figure'4:!Cultures!with!worst!parameters!show!improvement!in!vitro!and!in!vivo!with!metalloproteinase!inhibition.!Donors!A,!E!and!F.!
A:!Average!GAG!secretion!is!significantly!higher!and!shows!significantly!less!variation!with!Merimastat!(MI)!compared!to!normal!culture.!3!
donors!with!3!replicates!each!were!used.!B:!Bone!volume!fraction!is!significantly!higher!in!samples!cultured!with!MI.!(**=P<0.01)!C:!Bone!
volume! does! not! show! a! significant! difference,! though! trend! is! higher.! E:! Representative!HE! staining! of! sample!without!MI.!White! bar!
represents!100μm.!F:!Representative!HE!staining!of!sample!with!MI.!White!bar!represents!100μm.!
Cultures(with(worst(parameters(show(improvement(in(vitro(and(in(vivo(
with(metalloproteinase(inhibition((
We! hypothesized! that! the! CD45+! cells! could! represent! bone! marrow! derived! macrophages,!
which! may! secrete! metalloproteinases! to! digest! cartilage(25).! Therefore,! to! improve! tissue!
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formation,!a!general!metalloproteinase! inhibitor!was!added! to! the! culture!medium.!Although!GAG!
secretion!in!the!supernatants!did!not!reach!the!level!of!the!best!cultures,!MMP!inhibition!did!lead!to!
a!significant!increase!(P<0.01!for!each!time!point)!as!well!as!decreased!variability!between!replicates!
(Figure! 4A).! After! 12! weeks! in! vivo,! Bone! volume! fraction! was! significantly! greater! (P<0.01)! in!
samples!cultured!under!MMP!inhibition,!though!absolute!bone!volume!was!not!significantly!different!
(Figure! 4B! and! C).! Histological! evaluation! showed! that! although! in! both! conditions! dense! eosinE
positive!tissue!formed,!only!MMP!inhibition!lead!to!bone!marrow!formation!(Figure!4D!and!E).!
Correlation(of(in(vitro(parameters(with(in(vivo(bone(volume(
Finally,!GAG!and!ALP!content! in! supernatants!during! the!culture!period!were!correlated! to! the!
bone!volume!after!12!weeks!in!vivo!as!measured!by!microtomography!in!mm3.!!For!both!parameters,!
the! sum!over! all! time!points! and! single!peak! values! after! 7!days!of! culture! significantly! correlated!
with!bone!volume!(Table!1).!
!
Table' 1:! Correlation! of! in! vitro! parameters! with! in! vivo! bone! volume.! Absolute! bone! volumes! (in! mm3)! measured! by!
microtomogrpahy!were!correlated!to!in!vitro!paramter!of!4!donors!with!3E4!replicates!each!(Donors!R11,!A,!E,!F).!!!
Discussion(
In! this! study! we! have! showed! that! perfusion! bioreactor! based! culture! of! rabbit! BMSC! on! a!
collagen!type!I!scaffold!can!lead!to!formation!of!homogenous!hypertrophic!cartilage.!Measurement!
of! glycosaminoglycans! and! alkaline! phosphatase! during! medium! change! allows! atElineEmonitoring!
and!can!be!correlated! to! the!GAG!content!and!percentage!of!cartilage!area!of! the! resulting! tissue.!
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More!importantly,!we!could!correlate!our!monitoring!parameters!with!in!vivo!bone!formation!after!
12!weeks.!!
In!view!of!the!principles!proposed!by!Lourenco!et!al(16)!and!Gardel!et!al(17)!we!have!shown!that!
relevant! realEtime!monitoring! is!possible! in!perfusion! culture!of!engineered!hypertrophic! cartilage.!
Since! the!parameters! involve! sampling!of! the! supernatant,! they! cannot!be! considered!as! “online”,!
although! it! is! possible! to! develop! sensors! for! actual! online! measurement(18).! ! However,! both!
proposed!parameters! can!be!measured! in! less! than!2!hours! and! accumulate! gradually! in! between!
medium! changes.! Based! on! this,! one! can! rapidly! judge! the! wellbeing! of! the! culture! by! using!
measurements!before!each!medium!change.!Other!proposed!parameters!such!as!alamar!blue!for!cell!
growth!and!viability(26),!O2!and!CO2(27)!or!pH(28)!would!also!allow!culture!monitoring.!In!our!specific!
bioprocess! however,! the! function! of! hypertrophic! cartilage! crucially! depends! on! the! amount! and!
quality! of! extracellular! matrix(29E31)! and! features! the! apoptosis! of! hypertrophic! chondrocytes! at!
later!maturity!stages(29,!32).!It!is!therefore!not!possible!to!rely!on!cell!metabolism!alone!in!order!to!
predict!the!outcome!of!the!culture.!
In! the! context! of! bioreactors! both! glycosaminoglycan! content! as! a! surrogate! for! cartilage!
formation(18)! and! alkaline! phosphatase! as! a! surrogate! for! ossification(17)! have!been!measured! in!
the!tissues!at!the!end!of!culture.!In!both!cases,!the!aim!has!been!to!show!that!perfusion!cultures!can!
improve! these! parameters! compared! to! static! cultures.! However,! the! same! parameters! have! not!
been! up! to! now! used! in! supernatants! to! nonEinvasively! monitor! cultures! and! predict! in! vivo!
performance.! Glycosaminoglycans! are! crucial! components! of! the! cartilage! matrix,! giving! it!
mechanical!stability!due!to!the!Donnan!ion!distribution!law(18)!and!thus!being!intimately!tied!to!the!
size! of! the!wet! tissue.! However,! they! also! bind! diverse! signaling!molecules! such! as! FGF(33),!Wnt,!
BMP,! Ihh! and! others(34E36)! and! could! represent! a! surrogate! measure! for! the! content! of! these!
molecules!in!the!matrix.!!Alkaline!phosphatase!is!found!in!several!tissues(37).!It!exerts!one!of!its!main!
functions! in! bone,!where! it! guides!mineralization! in! a!membrane!bound! form!both!on!osteoblasts!
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and!on!small!vesicles(38).!Already!Kato!et!al(39)!could!show!that!micromass!cultures!of!rabbit!growth!
plate! chondrocytes! forming! hypertrophic! cartilage! display! alkaline! phosphatase! activity! that!
correlates! with! collagen! type! X! production.! The! enzyme! is! accepted! as! a! crucial! part! of! the!
endochondral!ossification!process!during!cartilage!matrix!calcification(29).!
The!use!of!rabbit!cells!in!our!study!was!motivated!by!the!necessity!for!a!future!preEclinical!model.!
Although!orthotopic! implantation!of!engineered!hypertrophic! cartilage!has!been!performed! in! rats!
and!mice,! larger! animal!models! such!as! rabbits,! sheep,! goats!or!pigs! are! required.!Rabbits! are! the!
least!expensive!and!easiest!to!handle!and!allow!a!variety!of!clinically!relevant!setEups!including!very!
challenging! segmental! defects(19).! Also! rabbit! bone! marrow! stromal! cells! are! known! to! form!
cartilaginous!tissue!without!the!requirement!to!sort!specific!subEpopulations(40).!To!our!knowledge,!
this!is!the!first!description!of!bone!formation!from!hypertrophic!cartilage!produced!in!a!bioreactor!by!
rabbit! MSC.! The! variability! of! cartilage! formation! with! different! rabbit! donors! is! in! line! with!
observations! in! human!MSCs(6).! Although! in! principle! xenogenic! tissue! can! be! used! in! clinics,! for!
future!studies!we!aim!to!verify!our!monitoring!parameters!in!human!cultures!as!well.!Based!on!the!
similarity!of!hypertrophic!cartilage!and!in!vivo!bone!formation,!we!expect!a!high!transferability.!
The! detection! of! GAG! was! significantly! correlated! with! final! tissue! GAG/DNA! ratio! and!
percentage! of! cartilaginous! area! in! nonEhomogenous! cultures.! This! opens! the! possibility! to! obtain!
information! on! the! quality! of! the! tissues! in! a! perfusion! bioreactor! culture! in! a! nonEdestructive!
manner.!6!of!the!7!donors!we!analysed!did!not!form!completely!homogenous!tissue,!which!could!be!
explained! by! the! presence! of! CD45+! bone! marrow! derived! macrophages,! which! are! known! for!
metalloproteinaseEmediated! cartilage! digestion(25).! Thus,! the! inhibition! of! metalloproteinases(41)!
improved!GAG!secretion!and!in!vivo!performance!of!the!bioreactor!cultures.!It!has!not!been!shown!
that!CD45+! cells! from! rabbit! bone!marrow!can!be! coEcultured!with!MSC!and!extensively!passaged!
under!the!conditions!chosen!in!this!study.!Although!CD45!is!a!pan!hematopoietic!marker,!the!most!
likely! candidate! cells,! which! can! attach! to! culture! plastic! and! are! found! in!MSC! cultures! of! other!
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species,! are!macrophages(42).! However,! no! CD45+! cells! have! been! described! in! expanded! human!
MSC!using!similar!conditions.!
!Most!intriguingly,!both!GAG!and!ALP!were!strongly!correlated!with!the!in!vivo!bone!formation.!
One! has! to! keep! in! mind! that! the! process! of! endochondral! ossification! requires! the! complete!
remodelling! of! hypertrophic! cartilage(29).! Therefore,! our! proposed! monitoring! parameters! give!
insight! not! only! into! the! integrity! of! the! culture,! but! also! into! further! tissue! maturation! and!
remodelling! in! vivo.! To! our! knowledge,! this! is! the! first! work! showing! this! type! of! correlation! and!
providing!surrogate!measures!to!judge!final!in!vivo!performance.!
Future!application!of!hypertrophic!cartilage!as!a!bone!substitute!material!will!require!largeEscale!
production! to! meet! clinical! demands.! ! BioreactorEbased! production! could! offer! many! advantages!
such!as!an!increased!tissue!size,!improved!reproducibility!and!easier!handling.!Monitoring!will!allow!
identification! of! the! tissues! (from! different! donors! and/or! experimental! replicates)! capable! to!
efficiently! induce! bone! formation.! Consequently,! the! otherwise! extensive! in! vivo! testing! could! be!
significantly!reduced.!!
Conclusion(
This! present! study! identified! and! analyzed! two! monitoring! parameters,! GAG! and! ALP,! in! the!
supernatants! of! perfusion! bioreactor! based! cultures! of! engineered! hypertrophic! cartilage.! A!
correlation!of! the!monitoring!parameters! to! tissue!quality! and! also! to! in! vivo!bone! formation!was!
presented.! The! results! of! this! study! can! be! used! to! improve! the! future! efficiency,! productivity,!
reproducibility!and!most!importantly!quality!of!this!type!of!culture.!
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Interaction of CD14+ monocytes and engineered hypertrophic 
cartilage during end-stage endochondral ossification Atanas Todorov1, Celeste Scotti1,2, Andrea Barbero1, Arnaud Scherberich1, Adam Papadimitropoulos1, Ivan Martin1 
1 Departments of Surgery and Biomedicine, University Hospital Basel, Hebelstrasse 20, CH-4031 Basel, Switzerland 
2 Orthopaedic Institute I.R.C.C.S. Galeazzi, Via R. Galeazzi 4, 20161 Milan, Italy 
Abstract Endochondral ossification of engineered hypertrophic cartilage (HC) is a valuable model for bone growth and regeneration. Factors contained in the hypertrophic matrix such as VEGF or BMP-2 are released by monocyte-/osteoclast-derived MMP-9 and chondrocyte-derived MMP-13. Gently devitalized HC contains similar levels of these factors and is osteoinductive, though less efficient. We hypothesized that additional monocytes and osteoclasts could improve bone formation by digesting HC, releasing factors and attracting osteogenic progenitors. We seeded living or devitalized HC with human blood-derived monocytes and either maintained samples under osteoclastogenic conditions or implanted them in nude mice. Monocytes and osteoclasts invaded HC in vitro and led to the release of proteins. Levels of G-CSF, IL-6, MMP-13, VEGFa and FASL were significantly higher in living compared to devitalized samples. Monocytes, but not MSC or HUVEC, migrated towards the released signals. The addition of monocytes in vivo did not result in more efficient bone formation, yet the bone volume fraction correlated with protein secretion in vitro and the presence of osteoclasts, endothelial cells and macrophages in vivo. In conclusion, seeding of osteoclastogenic monocytes was 
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not sufficient to improve bone formation of living or devitalized hypertrophic cartilage. While common precursor monocytes could be attracted by devitalized matrix, their survival and differentiation into osteoclasts depended on interactions with hypertrophic chondrocytes. Presence of M2 macrophages was correlated with subsequent vascularization.  Our model is consistent in vitro and in vivo and improves the understanding of end-stage endochondral ossification. 
Keywords endochondral ossification, monocytes, osteoclasts, hypertrophic chondrocytes, macrophages, G-CSF, IL-6, MMP-13, VEGFa, FASL 
Introduction Transformation of hypertrophic cartilage into bone tissue is observed during growth and fracture repair of long bones. Remodelling of hypertrophic cartilage can be particularly important in diseases such as juvenile idiopathic arthritis(1, 2), where both growth retardation and growth excess have been described as a result of inflammation. Clinical management of fracture healing through callus formation can equally benefit from an improved understanding of this process. Fractures and the associated morbidity and mortality represent a significant burden(3), resulting in a great need to develop more effective pharmacological treatments and novel bone substitute materials.   
Engineered hypertrophic cartilage undergoes endochondral ossification in a process which closely resembles long bone development(4). The transition from hypertrophic matrix  to bone is highly dependent on MMP-mediated matrix degradation and attraction of endothelial cells and mesenchymal stromal cells(5-7). Factors such as VEGF or BMP-2 in the hypertrophic matrix are released by monocyte-/osteoclast derived MMP-9 and chondrocyte-derived MMP-13 during remodelling(5) and have an 
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osteoinductive effect. Gently devitalized hypertrophic matrix contains similar levels of cytokines and growth factors compared to living matrix, but shows a much less efficient bone formation(8). Possibly, the lack of MMP-13 from hypertrophic chondrocytes leads to less cytokine release(5, 9, 10) and therefore less attraction of monocytes and development of osteoclasts(11). In the growth plate of MMP-13 knockout mice upregulation of MMP-9 by monocytes and osteoclasts may however be sufficient for bone formation(10). Although monocytes are attracted to any implanted graft due to an initial immune reaction(12, 13), their number, mode of activation and lack of differentiated osteoclasts may be insufficient for bone formation. However, if monocytes primed to become osteoclasts can be brought into contact with devitalized hypertrophic matrix, they may improve the release of cytokines and growth factors and thus enhance the osteoinductivity. 
CD14+ monocytes from peripheral blood are precursors for both osteoclasts and macrophages(14, 15). They can be easily collected, purified and immediately stimulated with RANKL and M-CSF(16) to yield multinucleated osteoclasts, which are fully functional(17, 18).  
Our hypothesis in the present study was that primed osteoclastogenic CD14+ monocytes could be seeded on devitalized hypertrophic cartilage, resulting in matrix degradation and release of cytokines, which in turn would attract all necessary progenitor lineages for bone formation and would ultimately lead to increased efficiency of bone formation in vivo. Our aim was to first establish a co-culture system and subsequently identify the most important factors released. In a second step we implanted the seeded matrix to verify bone formation in vivo.  
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Materials and Methods 
Generation of hypertrophic cartilage Hypertrophic cartilage was generated as described previously(4). Bone marrow mesenchymal stromal cells were extracted from 5 healthy human donors (male, 33.8+-6.8  years) after informed consent (ethical approval at the University Hospital Basel, reference 78/07 ) and expanded using complete medium (alphaMEM, 10% FBS, 1mM sodium pyruvate, 10mM HEPES, 1% penicillin-streptomycin-glutamine, all from Gibco, Basel, Switzerland) with 5 ng/ml FGF2 (R&D Systems, Wiesbaden, Germany) up to 4 passages. Cells were detached using 0.5 mg/ml trypsin (Gibco), collected and resuspended in chondrogenic medium consisting of serum free medium (DMEM, 1.25 mg/ml human serum albumin, 1 mM sodium pyruvate, 10 mM HEPES, 1% penicillin-streptomycin-glutamine, 1% ITS-1, all from Gibco) together with 10 ng/ml TGFβ1 (R&DSystems), 10-7 M dexamethasone and 0.1 mM ascorabic acid 2-phosphate (Sigma Aldrich, Buchs, Switzerland). In the first experiment, a transwell system (0.4 µm membrane pores 24-well-plate, Corning, Root, Switzerland) was used. All subsequent experiments were performed with 1.5 ml screwcap tubes (Sarstedt, Sevelen, Switzerland). 5×105 cells were centrifuged at 400g for 5 minutes to form cell aggregates and incubated in a standard incubator at 37°C and 5% CO2. Medium changes were performed twice per week and chondrogenic medium was used for the first 3 weeks. After this peroid, hypertrophic medium consisting of serum free medium with 0.05µM L-thyroxine, 10-6M dexamethasone, 10 mM β-glycerophosphate and 0.1 mM ascorbic acid 2-phosphate (all from Sigma Aldrich) was used for an additional 2 weeks. 
Devitalization of hypertrophic cartilage Samples were subjected to freeze/thaw devitalization as described previously(8). Briefly, samples were transferred to 15ml plastic tubes and frozen in liquid nitrogen (-
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192°C) for 10 minutes, then thawed in a water bath at 37°C for 10 minutes. This cycle was repeated 3 times and the samples finally rinsed with bidistilled water.  
Isolation of CD14 positive monocytes Peripheral blood buffy coats from healthy donors were used and mononuclear cells separated by gradient centrifugation (Ficoll, Histopaque 1077, Sigam-Aldrich) as previously described(19). CD14+ monocytes were sorted using anti-CD14 coated magnetic beads (Miltenyi Biotec, Auburn, CA, USA) according to the manufacturer’s	  instructions.  
Co-cultures CD14+ monocytes were resuspended in co-culture medium (alpha-MEM, 1 mM sodium pyruvate, 10 mM HEPES, 1% penicillin-streptomycin-glutamine, all from Gibco) with 25 ng/ml M-CSF and 50 ng/ml RANK-ligand (R&D systems). As controls, monocytes were seeded on tissue culture plastic to evaluate osteoclast formation. Living or devitalized hypertrophic matrix was incubated with 1-5 million monocytes on an orbital shaker for 24 hours at 37°C. Seeding efficiency was analyzed by incubation with 0.05 mg/ml tetrazolium salt (MTT, Sigma-Aldrich) in phenol-free medium (DMEM, Gibco) for 4 hours at 37°C. MTT was then dissolved with DMSO (Sigma-Aldrich), absorption measured at 575 nm and compared to a monocyte standard curve. After seeding, co-cultures were gently transferred to conical 96-well plates (Corning). Medium changes were performed twice per week and the supernatants frozen at -20°C for later analysis.  
Whole mount staining Samples were fixed in 4% PFA for 15 minutes and incubated with ELF-97 (200 µM ELF-97 from Thermo Fisher Scientific, 0.2 M sodium acetate and 50 mM L(+) tartaric acid from Sigma-Aldrich, pH 5.0) for 15 minutes at 37°C to visualize tartrate resistant 
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acid phosphatase (TRAP). After washing, samples were incubated with primary antibody for human calcitonin receptor (ab175297, Abcam, UK).  Secondary antibody conjugated with AlexaFluor647 (Dako, Baar, Switzerland), FITC conjugated phalloidin and DAPI (Sigma-Aldrich) were added. The samples were analyzed under a Nikon A1 confocal microscope. 
Glycosaminoglycan and DNA content  For the measurement of glycosaminoglycans (GAG) and DNA, co-culture samples were digested overnight with Proteinase K solution (1 mg/ml Proteinase K in 50 mM Tris pH 7.6, 1 mM EDTA, 1 mM Iodoacetamide, 10 µg/ml Pepstatin, all from Sigma Aldrich). GAG measurements were performed as described previously(20). Briefly, GAG was precipitated with DMMB, centrifuged and re-dissolved. Absorption was measured at 656 nm and GAG concentrations calculated using a standard curve. DNA measurements were performed with the CyQuant kit (Thermo Fisher Scientific, Zug, Switzerland) according to the manufacturer’s	  protocol. 
Migration analysis  Supernatants from co-cultures were diluted 1:2 in fresh co-culture medium and distributed in the bottom chambers of 96-well transwell plates (HTS transwell, 8.0 µm pore size, polyester membrane, Corning) pre-coated with 1% gelatin. 5×104 cells in co-culture medium were pipetted in the top chambers. Human MSC of 3 donors were used after 2 passages as described above. HUVEC expanded for 4 passages were kindly provided by Prof. Anna Marsano. CD14+ monocytes were used directly after sorting as described above. Plates were incubated for 24 hours at 37°C, then centrifuged at 400g for 2 minutes and bottom chambers incubated with 1 µM Calcein AM for 15 minutes at 37°C. Fluorescence of the bottom chambers was read at 480 nm excitation and 520 nm emission.  
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Osteogenic differentiation of MSC In parallel to the migration analysis, human MSC were resuspended in complete medium and seeded at a density of 5000 cells / cm2 in 96 well plates. Differentiation was induced by osteogenic medium (complete medium, 10-6 M dexamethasone, 10 mM β-glycerophosphate and 0.1 mM ascorbic acid 2-phosphate) with supernatant mixed 4:1. After 3 weeks of differentiation, alkaline phosphatase activity was measured(21). Briefly, 50ul buffer (5 mg/ml p-nitro-phenyl phosphate, 200 mM TRIS, 1 mM MgCl2, pH 9.5) were added to each well and incubated for 30 minutes at 37°C. The reaction was stopped by addition of 50 µl 1 M NaOH, absorption was measured at 405 nm and ALP activity was calculated using a standard curve. 
Analysis of GAG and proteins in supernatants Supernatants were analyzed for GAG as described above, except that no Proteinase K digestion was performed. The content of a panel of growth factors, chemokines, and metalloproteinases was analyzed by multiplex protein assay according to the 
manufacturer’s instructions (Procarta Immunoassay Kit; Panomics). 
Implantations All animal procedures were reviewed and approved by the Swiss Federal Veterinary Office (BS 1797).  Female 6-8 week old nude mice were anaesthetized using 2% isoflurane in 1l/min O2. The skin was disinfected and cut 8mm along the dorsal midline. Subcutaneous pockets were prepared by blunt dissection on both sides. Samples were implanted directly after seeding as mentioned above. The wounds were closed with surgical staples and the animals allowed to recover under red light. Regular checks were performed and staples removed after 7-10 days. Animals were euthanized in a CO2 chamber after 3 or 8 weeks and samples fixed in 1.5% PFA before further analysis. 
Microtomography 
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Microtomography was performed using a tungsten x-ray source at 70kV and 260 µA with a 0.5 mm aluminium filter (Nanotom M, GE, USA). Transmission images were acquired for 360° with an incremental step size of 0.25°.  Volumes were reconstructed using a modified Feldkamp algorithm (software supplied by manufacturer) at a voxel size of 2.5 – 3 µm. Thresholding, segmentation and 3D measurements were performed using the ImageJ(22) software with the BoneJ(23) and 3D Shape(24) additions.  
Histology Samples were embedded in paraffin and sections of 5μm thickness prepared using a microtome. Safranin-O, Masson tri-chrome and tartrate resistant acit phosphatase (TRAP) stainings were performed as published previously (Scotti 2010, Scotti 2014). Primary antibodies for DIPEN (1042002, MDBiosciences, USA), collagen type I (ab6308), collagen type II (ab34712), collagen type X (ab49945), bone sialoprotein 
(ab52128), MMP-9 (ab38898), MMP-13 (ab39012, Abcam, UK), CD31 (ab28364) and 
Sca1 (ab51317) were used. After washing and incubation with an appropriate biotinylated secondary antibody (Dako, Denmark), the stainings were developed with 
the	   Vectastain	   ABC	   kit	   (Vector	   Laboratories,	   USA)	   according	   to	   the	   manufacturer’s	  protocols.  
Fluorescent double staining with conjugated antibodies for F4/80 (MCA497A647, AlexaFluor 647, AbDSerotec, Germany) and CD206 (MCA2235A488, AlexaFluor 488, AbDSerotec) was performed to identify M2 macrophages(25) and DAPI (Sigma Aldrich) added.  
Quantifications Samples were completely sectioned and four to six sections spaced at regular intervals were quantified. For osteoclasts, TRAP positive multinucleated cells were counted. For endothelial cells, CD31 positive cells were counted. For M2 macrophages, 
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F4/80 and CD206 double positive cells were counted. Only cells inside the implanted matrix or attached to the outer surface were counted and total sample area was considered for counting.  
Statistical Analysis Data was analyzed by t-test, ANOVA and Pearson correlation using the GraphPad Prism v2.2 software. A significance level alpha of 0.05 was set. Average values and standard deviations are reported. 
Results 
In vitro co-culture of hypetrophic cartilage matrix and CD14+ 
monocytes After 5 weeks of in vitro generation, both disks and pellets of hypertrophic cartilaginous matrix (Supplementary Figure 1) showed a typical morphology and presence of molecular markers (collagen I/II/X, BSP) as previously published(4) . Seeing that transwell culture randomly formed disks or pellets, standardized pellet culture was used for 4 out of 5 donors. One million monocytes were used for seeding, since independently from the intial concentration 5.2±1.1×105 cells attached. At day 7, control cultures of monocytes on plastic differentiated into multinucleated TRAP-positive osteoclasts (Supplementary Figure 2). At the same time, whole mount stainings showed monocytes forming actin rings on the surface of devitalized hypertrophic matrix. Multinucleated cells positive for TRAP and human calcitonin receptor were also observed (Figure 1A and B). Histological sections additionally showed TRAP positive monocytes inside the matrix (Figure 1C). Monocytes and multinucleated cells on the living matrix were also positive for TRAP and human calcitonin receptor (Figure 1D), but their actin filaments were organized in long strands.  
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Figure 1: A: 7 days whole-mount staining of devatilzed matrix with tartrate resistant acid phosphatase (TRAP) and human calcitonin receptor (hCTR) positive cells forming actin rings. B: Closeup of TRAP and hCTR positive multinucleated cell on the devitalized matrix. C: TRAP-stained section of devitalized sample shows mononucleated cells invading the matrix. D: Living matrix with TRAP and hCTR positive cells, elongated actin filaments. Bars in A-D represent 50 µm. E: GAG secretion in supernatant over the culture period. Devitalized seeded samples have significantly more GAG in the supernatant at all time points (P<0.01). F: Safranin-O staining after 15 days of co-culture. Devitalized seeded show decreased thickness. L = living, L14 = living seeded, D = devitalized, D14= devitalized seeded. Bar in L represents 200 µm. G: GAG content of the matrix after 15 days. GAG is significantly lower in devitalized seeded samples. H: TRAP staining 
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after 15 days. Living seeded samples display TRAP positive single and multinucleated cells invading the matrix. Bar in L14 represents 50 µm, in D14 100 µm. 
In vitro digestion of devitalized hypertrophic cartilage During the co-culture for up to 15 days, all groups secreted glycosaminoglycans (Figure 1E). Seeded devitalized samples released significantly more GAG than all other groups (P<0.01 for all time points and groups). Seeded devitalized matrix showed a reduced volume and loss of Safranin-O positivity (Figure 1F). Significantly less GAG was present in the seeded devitalized matrix (Figure 1G). After 15 days, TRAP positive multinucleated cells were found invading the living matrix, but no cells were found in the devitalized matrix (Figure 1H).   
Differences between living and devitalized matrix in co-culture  Using supernatants from the 3rd day of co-culture, migration and alkaline phosphatase activity of human MSC and migration of HUVEC were not affected by any of the groups (Supplementary Figure 3). However, freshly isolated CD14 monocytes showed more migration towards supernatants from seeded living and devitalized samples compared to controls and compared to devitalized matrix only. 
Since digestion, monocyte attraction and invasion were observed with seeded living or devitalized matrix and protein secretion was greatest at 3 days, further analysis was performed only on these samples. Supernatants were analyzed for a panel of cytokines, growth factors and metalloproteinases (Table 1). G-CSF was only detected in living samples (Figure 2). IL-6, MMP-13 and VEGFa were significantly higher in living versus devitalized samples. Interestingly, FASL was significantly lower after 3 days, but significantly higher after 7 days in living compared to devitalized samples. All other factors, including the most abundant IL8, did not show significant differences (Supplementary Figure 4). TGFβ1 was not detected in any group. 
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Table 1: Proteins chosen for analysis of supernatants. Dimitriou 2005(26), Bastian 2011(27), Blin-Wakkach 2014(28), Katavic 2003(29), Kovacic 2007(30), Fujihara 2014(31), Deshmane 2009(32), Graves 1999(33), Kitaori 2009(34), Dai 2007(35), Boyce 2008(36), Iqbal 2009(37) 
Protein Relation to Endochondral Ossification
IL6 cytokine, initiates repair cascade during fracture healing (26)
IL8 cytokine, primes neutrophils during fracture healing (27)
G-CSF can increase osteoclast number, involved in HSC niche 
formation by osteoclasts (28)
FASL mediates apoptosis of leukocytes, important for early bone 
morphogenesis (29), limited role for apoptosis of osteoblasts 
and osteoclasts (30) creates immune privilege for 
engineered cartilage (31)
MCP-1 attracts monocytes (32), implicated in bone remodeling (33)
SCF chemoattractant, invovled in HSC niche (28), stem cell 
mobilisation and effect on osteoblasts 
SDF-1 chemoattractant, invovled in HSC niche (28), recruitment of 
MSC to fracture site (34)
VEGFa Expressed during endochondral ossification, responsible for 
vascularization (26), can regulate chondrocyte and 
osteoblast fate (35)
MMP-9 allows remodelling during final stages of endochondral 
ossification (26)
MMP-13 allows remodelling during final stages of endochondral 
ossification (26)
OPG binds to RANKL and regulates osteocalst formation and bone 
resorption (36), important for resorption of calcificed 
cartilage
BMP-2 promotes endochondral ossification and bone formation (26), 
responsible for callus formation 
BMP-4 promotes endochondral ossification and bone formation (26)
TGFβ1 promotes various stages of endochondral ossification (26), 
regulates bone homeostasis (37)
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Figure 2: Proteins in supernatants found to be significantly different between living and devitalized seeded groups after 3 days of co-culture. FASL was the only factor found to be significantly lower at 3 days and higher at 7 days in living seeded versus devitalized seeded samples. (*P<0.05;**P<0.01;***P<0.001) 
In vivo implantation of co-cultures leads to bone formation in living 
hypertrophic matrix Immediately after seeding, samples were implanted in nude mice. After 3 weeks both seeded and unseeded living implants displayed a very slight Safranin-O positivity, suggesting an ongoing loss of GAG (Figure 3A). Devitalized implants appeared devoid of GAG and with a fibrotic internal matrix surrounded by denser tissue. No apparent differences were found between the seeded and unseeded group. 
After 8 weeks living implants had formed frank bone tissue with bone marrow and a peripheral bone lamina (Figure 3B). Few remnants of the cartilaginous matrix could be distinguished, along with trabecular structures. Red-stained elastin was present in the osteoid of the seeded living implants, suggesting a more mature bone. Devitalized 
 ~ 78 ~  
implants showed areas of dense matrix containing cells and areas of cell free fibrotic matrix. No differences were observed between seeded and unseeded samples. 
 
Figure 3: A: Safranin-O staining of representative samples 3 weeks after subcutaneous implantation in nude mice. B: Masson tri-chrome staining of representative samples after 8 weeks in vivo. Bone marrow was observed exclusively in living samples. Red-stained elastin in living seeded implants indicates a more mature osteoid. Devitalized samples display areas of denser matrix and areas of loose fibrotic tissue without a qualitative difference between seeded and unseeded samples. Bars in A and B represent 50 µm. 
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Bone volume fractions were quantified using a threshold for bone tissue (Figure 4A). All living implants had significantly more bone than devitalized implants. However, seeded implants did not show any significant difference compared to unseeded implants. In seeded living implants versus unseeded living implants there was a trend towards more bone.  
In vivo presence of cell types necessary for bone formation The number of osteoclasts was significantly higher in all living versus devitalized implants (Figure 4B). Seeded implants were not significantly different from unseeded implants. The presence of endothelial cells was highly variable and did not show any significant trend (Figure 4C). There was a tendency towards less endothelial cells in devitalized implants. M2 macrophages were significantly higher in seeded living versus seeded devitalized implants (Figure 4D). No significant difference was found between seeded and unseeded implants. Non-M2 macrophages positive for F4/80 but not for CD206 and Sca1 positive putative MSC were only found sporadically.  
Correlation of bone formation with secreted proteins in vitro and 
attracted cell types in vivo Bone volume fraction (BV) was significantly correlated with the levels of in vitro secreted proteins. It was also correlated to the presence of osteoclasts and M2 macrophages, but not endothelial cells.  
Osteoclasts were only correlated with the secreted proteins, including FASL. M2 macrophages were correlated with G-CSF and IL-6. Endothelial cells only corrleated with the presence of M2 macrophages. 
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Figure 4: A: Microtomographical quantification of bone and mineralized matrix after 8 weeks in vivo. Living samples had significantly more bone thand devitalized samples. Seeding did not result in significant differences. B: Osteoclast quantification based on TRAP staining after 3 weeks in vivo. Living samples had significantly more osteoclasts than devitalized samples, seeding did not result in significant differences. Black bar is 50 µm. C: Endothelial cell quantification based on CD31 stainings after 3 weeks in vivo. No significant differences. Black bar is 50 µm. D: M2 macrophage quantification based on CD206 and F4/80 co-staining after 3 weeks in vivo. Living seeded samples had significantly more macrophages than devitalized seeded samples. Seeded versus unseeded differences were not significant. White bar is 20 µm. (*P<0.05;**P<0.01;***P<0.001) 
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Table 2: Significant correlations found between bone volume (BV), number of different cell types (OC = osteoclasts, CD31 = endothelial cells, M2 = M2-macrophages) and factors which were differentially expressed during co-cultures. Note: FASL values after 7 days are displayed. FASL values after 3 days were not significant in any correlation. 
Discussion In this present study, monocytes and osteoclasts invaded engineered hypertrophic cartilage in vitro and led to the release of proteins. Levels of G-CSF, IL-6, MMP-13, VEGFa and FASL were significantly higher in living compared to devitalized samples. Monocytes, but not MSC or HUVEC, migrated towards the released signals. The addition of monocytes in vivo did not result in more efficient bone formation, yet the bone volume fraction correlated with protein secretion in vitro and the presence of osteoclasts, endothelial cells and macrophages in vivo.  
CD14+ blood derived monocytes are a well described pool of progenitors for osteoclasts(14-18), though monocytes and possibly macrophages are present after differentiation.  Mononucleic TRAP positive cells can resorb bone but are less efficient than classical multinucleated osteoclasts(38). Monocytes can also differentiate to inflammatory (M1) or regenerative (M2) macrophages(25). As would be expected during endochondral ossification(39), our co-culture represents a mixture of all these cell types. Further selection of CD14+ monocytes for RANK expression could identify 
OC CD31 M2 IL6 MMP13 G-CSF VEGFa FASL* OPG
BV rho 0.90 n.s. 0.84 0.85 0.78 0.83 (0.72) 0.81 n.s.
R2 0.81 0.71 0.72 0.61 0.70 (0.52) 0.66
P 0.007 0.018 0.017 0.033 0.020 (0.052) 0.025
OC rho n.s. n.s. 0.89 0.91 0.85 0.93 0.86 n.s.
R2 0.79 0.83 0.73 0.86 0.74
P 0.018 0.012 0.031 0.008 0.029
CD31 rho 0.83 n.s. n.s. n.s. n.s. n.s. n.s.
R2 0.69
P 0.041
M2 rho (0.81) n.s. 0.82 n.s. n.s. n.s.
R2 (0.65) 0.67
P (0.052) 0.048
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primed osteoclast progenitors(40), but would decrease the relevance to the physiologic process.  
Although cells invaded both living and devitalized samples, digestion in vitro mostly affected devitalized matrix. This was in spite of the fact that MMP-13 was higher in living samples and MMP-9 was not significantly different. One could assume that both the living and devitalized matrix were digested and the living matrix could compensate the loss of protein, yet secretion and final content of glycosaminoglycans suggested that only devitalized samples were significantly affected.  
Fuller et al(41) have suggested that MMPs contribute little to bone resorption by osteoclasts, yet in hypertrophic cartilage, MMPs are viewed as crucial(42). MMP-9 knockout mice show a transient increase of the hypertrophic zone as well as a compensatory upregulation of MMP-13(43). MMP-13 knockouts similarly display increased hypertrophic zones, though upregulation of MMP-9 by TRAP positive cells may be sufficient for bone formation(10). However, in our model  no compensation between MMP-13 and MMP-9 was present.  
Contrary to our expectations, neither MSC nor HUVEC showed any migration, whereas CD14+ monocytes migrated equally toward supernatants from living and devitalized co-cultures. This was paralleled by the absence of MSC after 3 weeks in vivo and by the lack of correlation between endothelial cells and secreted proteins, especially VEGF.  
Considering these results, it is likely that the secreted proteins in living co-cultures are part of a regulatory loop between hypertrophic chondrocytes and monocytes. Il-6, VEGF, IL8(41) and G-CSF(44) can attract monocytes and stimulate formation of osteoclasts(35, 45, 46). In our cultures, IL-6, VEGF and G-CSF were significantly different between living and devitalized cultures but IL-8 was similar and most abundant, 
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suggesting that monocyte migration could be due to the presence of IL-8. VEGF did not elicit endothelial cell migration and correlated with osteoclasts instead of endothelial cells in vivo, suggesting that this potent angiogenic factor(35) more likely regulates osteoclasts during endochondral ossification. IL-6(47) and G-CSF(48, 49) have been shown to differentiate monocytes towards M2 macrophages and could also aid their survival(50), which fits the correlations we observed.  On the other hand, FASL secreted by chondrocytes could kill invading monocytes and M1 macrophages and thus protect the matrix, as has been shown in cartilage engineered with normal and FASL deficient chondorcytes(31). Interestingly, FASL has a limited appoptotic effect on osteoclasts(30) and may even aid their differentiation(51), which would explain the observed correlation to osteoclasts in our study.  
TGFβ1 is considered an important coupling factor for bone resorption and formation and is stored in osteoid matrix in a latent form(37, 52). However, we did not detect it in our co-cultures. Possibly, it does not play a significant role during matrix remodelling of hypertrophic cartilage.  
Surprisingly, endothelial cells correlated only with M2 macrophages, suggesting an interaction between these cell types. Macrophages are essentail for neovascularization during wound repair(53) and resident monocytes and macrophages in the skin are important during subcutaneous implantations(54). Yet, to our knowledge the role of M2 macrophages in vascularization of hypertrophic cartilage has not been described.  
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Figure 5: Interactions of monocytes and hypertrophic matrix. CD14 = monocytes, OC = osteoclasts, HC = hypertrophic chondrocytes, M1/M2 = polarized macrophages, IL-6/8 = Interleukin, VEGF = vascular endothelial growth factor, G-CSF = granulocyte colony-stinulating factor, FASL = Fas ligand.   
Taken together, our results show that endochondral ossification of engineered hypertrophic cartilage involves crucial interactions with both osteoclasts and macrophages (Figure 5). While common precursor monocytes could be attracted by IL-8, their survival and differentiation into osteoclasts may depend on MMP-13, IL-6, VEGF, G-CSF and FASL. Formation of M2 macrophages could also be dependent on IL-6 and G-CSF signaling and could be crucial for subsequent vascularization. Importantly, devitalized matrices lacking these interactive mechanisms could equally attract monocytes but fail to support differentiation of osteoclasts and M2 macrophages in vivo.  
The model system we describe here refines the current understanding of hypertrophic cartilage remodelling and endochondral ossification. Since the basis is engineered hypertrophic matrix, it is possible to modify single matrix components and singaling pathways of hypertrophic chondrocytes(8). It is also possible to control and 
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analyse monocyte-mediated digestion and signaling. The use of patient derived MSC and CD14+ monocytes opens the possibility to personalize pharmacological screenings and investigate rare disease phenotypes.  
In conclusion, seeding of osteoclastogenic monocytes was not sufficient to improve bone formation of living or devitalized hypertrophic cartilage. While common precursor monocytes could be attracted by devitalized matrix, their survival and differentiation into osteoclasts depends on interactions with hypertrophic chondrocytes. Presence of M2 macrophages was correlated with subsequent vascularization. Our consistent in vitro and in vivo model thus improves the understanding of end-stage endochondral ossification. 
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Supplementary figures 
 
Supplementary Figure 1: Morphological and molecular appearance of hypertrophic matrix after 5 weeks of in vivo culture. A: Pellet culture in polypropylene tubes. CI = collagen type I, CII = collagen type II, CX = collagen type X, BSP = bone sialoprotein, MMP13 = matrix metalloproteinase 13. Scale bar is 200 um. B: Transwell culture. Scale bar is 500um 
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Supplementary Figure 2: Seeding of CD14 monocytes and development of osteoclasts. Living monocytes were seeded onto deviatlized hypertrophic matrix. 24h later the number of attached cells was calculated with the use of MTT. Different seeding modalities (A) with variable monocyte numbers (B and C) were used. Regardless of modality or cell 
concentration,	   an	   average	   of	   520’000	   cells	   attached	   in	   aggregates	   (D).	   After	   1	   week	   of	   culture	   on	   plastic	   large	  multinucleated TRAP positive cells with actin rings had formed (E).  
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Supplementary Figure 3: Migration and differentiation studies using supernatants from the co-culture. Human MSC do not show any migration differences or difference in alkaline phosphatase activity between groups. HUVEC do not show any difference in migration between groups. Human CD14 migration is significantly higher in living seeded and devitalized seeded samples compared to devitalized samples. 
 
Supplementary Figure 4: Proteins which were not significantly different in living and devitalized seeded groups. No TGFb was found in any of the supernatants. 
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Abstract Engineered and devitalized hypertrophic cartilage (HC) has been proposed as an off-the-shelf bone substitute material potentially combining the features of osteoinductivity, resistance to hypoxia, capacity to attract blood vessels and potential to be customized for specific indications. However, as compared to the vital tissues, devitalized HC grafts have reduced efficiency of bone formation and longer remodeling times. In order to address these limitations, here we tested the possibility to activate devitalized HC by stromal vascular fraction (SVF) cells from human adipose tissue, which include mesenchymal, endothelial and osteoclastic progenitors. HC pellets generated by human stromal cells from bone marrow were devitalized by freeze/thaw and implanted ectopically in nude mice or in calvarial defects in nude rats, after embedding in fibrin gel with or without different amounts of SVF cells. Ectopically, SVF cells added to devitalized HC increased the amount of bone formation in a cell-number-dependent fashion and directly contributed to endothelial, osteoblastic and osteoclastic populations. Bone volume correlated with the number of implanted CD31+CD34+CD146+ endothelial progenitors. Also in the calvarial model, SVF activation of HC strongly enhanced bone tissue formation. Our findings outline a bone augmentation strategy based on devitalized allogeneic HC, intraoperatively activated with autologous SVF cells. 
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Introduction Clinical treatment of challenging bone defects often requires a suitable bone graft, yet extensive donor site morbidity and complication rates around 60%(1) pose significant problems to the use of autologous bone. Commercially available bone substitute materials typically lack intrinsic osteoinductive potential and the long-term integration into bone defects is not always warranted(2).  
The use of engineered hypertrophic cartilage is receiving an increasing consideration as a possible bone substitute, due to many inherent advantages. As a bradytroph and hypoxia-resistant tissue(3), it does not require immediate vascularization. Moreover, it has some initial mechanical stability and it embeds the biological signals for the remodelling into a complete bone organ, resembling the processes of embryonic bone development (4). Although the bone forming capacity of engineered hypertrophic cartilage has been demonstrated in stringent ectopic implantation models as well as in an orthotopic non-union model (5-9), clinical translation can be hampered by the required use of autologous cells, their known and unpredictable variability across different donors, and the long times for in vitro construct generation.  
Devitalization and off-the-shelf storage of engineered, allogeneic hypertrophic cartilage could offer an attractive bone substitute material, based on the assumption that the deposited extracellular matrix (ECM) would physiologically deliver a suitable combination of cytokines and morphogens to recruit and instruct endogenous osteoprogenitors at the repair site(10). Previous work has shown that the signals necessary for osteoinduction can be preserved in the ECM, provided a mild but effective devitalisation strategy(11). Yet, the efficiency of bone formation remains reduced as compared to the vital tissue. Moreover, this difference is expected to become increasingly relevant along with the graft size, due to the time required by host cells to penetrate and reactivate the matrix, a pre-requisite for tissue remodelling into bone(12).  
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Inspired	  by	  the	  “developmental	  engineering”	  concept	  of	  modularity,	  whereby	  “the	  interfaces	  
between	  developing	  entities	  are	  initially	  uncoupled”(13), here we investigated the possibility of using multiple small organoids of engineered and devitalized hypertrophic cartilage to generate a larger bone volume. The strategy is based on the rationale that each construct would efficiently develop into bone tissue as an independent module, due to the large surface area to volume ratio, and the tissues would then fuse into a monolithic trabecular structure. 
In order to enhance the reactivation and remodelling of the devitalized ECM, we further introduced the use of stromal vascular fraction (SVF) cells, freshly harvested from human adipose tissue and embedded within a gel along with the devitalized cartilage matrix. The rationale was based on the fact that SVF cells contain endothelial progenitors, monocytes and mesenchymal stromal cells(14), with the respective capacity to potentially enhance tissue vascularization, osteoclast-mediated remodelling and bone formation.  
The goal of the present study was thus to test the hypothesis that the supplementation of human SVF cells to multiple pellets of engineered & devitalized hypertrophic cartilage leads to a composite construct with enhanced capacity to form de novo bone tissue, both ectopically (i.e., subcutaneously in nude mice) and orthotopically (i.e., in a calvarial defect model in nude rats).   
Materials and Methods All human samples were collected with informed patient consent and after approval by the local ethical committee, in accordance to Swiss law. Animal procedures were approved by the Swiss Federal Veterinary Office (Kantonal permit BS-2590). 
Preparation of devitalized hypertrophic constructs Human bone marrow stromal cells from 5 donors (35.4 ± 11.3 years, all male) were expanded for 2 passages in complete medium (alpha-MEM, 10% fetal bovine serum, 10 mM HEPES, 1 mM sodium pyruvate, 100 U/mL penicillin, 100	  μg/mL	  streptomycin, 0.29 mg/mL  
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glutamate, all from Invitrogen) containing FGF-2 (5 ng/mL, R&D systems, USA), as previously described(15).  Pellets were prepared by centrifuging 0.5x106 cells in 1.5 mL screw cap Eppendorf tubes at 300 g for 5 minutes and cultured in serum free medium (DMEM, 1.25 mg/mL human serum albumin, 10 mM HEPES, 1 mM sodium pyruvate, 100 U/mL penicillin, 100	  μg/mL	  streptomycin, 0.29 mg/mL glutamate and ITS-A [10	  μg/mL	  insulin,	  5.5	  μg/mL	  transferrin, 5 ng/mL selenium, 0.5 mg/mL bovine serum albumin] from Invitrogen) supplemented with  10 ng/mL TGF-E1 (R&D Systems), 10-7M dexamethasone and 0.1 mM ascorbic acid 2-phospahte (Sigma-Aldrich) (chondrogenic medium). After 3 weeks, resulting cartilaginous pellets were further cultured in hypertrophic medium (serum free medium with 50 nM thyroxine, 10 mM β-glycerophosphate, 10-8 M dexamethasone, 0.1 mM ascorbic acid 2-phosphate and 50 pg/mL IL-1E, Sigma-Aldrich) for 2 weeks, as previously described(15, 16). The generated hypertrophic pellets were devitalized using 3 cycles of freezing (-196°C for 10 minutes) and thawing (37°C for 10 minutes) and a final wash with deionized water. Pellets were stored at -80°C until further use. 
Isolation of SVF cells SVF cells from liposuctions or excision fat were isolated from 12 donors (33.7 ± 7.7 years, 2 males and 10 females) as described previously(17, 18). Briefly, minced fat tissue was incubated for 60 minutes in 0.15% collagenase type 2 solution, centrifuged and supernatants discarded. Cells were resuspended, filtered through 100 Pm mesh filters and counted in a Neubauer counting chamber using crystal violet. FACS analysis for CD31, CD34, CD146, CD90, CD105 and CD15 (AbD Serotec, USA) was performed as previously described(17).  Cells were frozen in fetal bovine serum and 10% DMSO and kept in the gaseous phase of liquid nitrogen until further use. 
Preparation of grafts SVF cells were thawed, counted and the appropriate amount resuspended in 40 PL fibrinogen (100 mg/mL, Tisseel, Baxter USA). Control samples contained no SVF cells. Multiple devitalized hypertrophic pellets (12 to 24, depending on the experiment, but constant for all 
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groups in one experiment) were mixed with this solution and 40 PL of thrombin (400 units/mL with 40 PM CaCl2, Tisseel, Baxter USA) were added. Polymerization was allowed to occur for 30 minutes at 37°C, followed by immediate implantation. 
Ectopic and orthotopic implantation For ectopic implantations, grafts were inserted into subcutaneous pouches of nude mice (CD-1 nude/nude, Charles River Laboratories) at 4 pouches per mouse, with duplicate grafts per donor and experimental group. The operation was performed with Isoflurane (Attane Isoflurane, Provet AG, Switzerland) anaesthesia and Buprenorphine (Temgesic, Reckitt Benckiser AG) analgesia and animals were checked periodically. After 12 weeks, mice were euthanized with CO2 and explants were assessed as described below. 
For orthotopic implantations, nude rats (RNU, Charls River Laboratories) were anesthetized using Isoflurane and the calvaria were exposed by dissection of the subcutaneous tissue and periosteum. Bilateral 4 mm defects were created in the central area of each parietal bone using a saline-cooled trephine bur. The defect was refined using a piezoelectric knife in order not to injure the dura mater. The sites were constantly irrigated with sterile NaCl 0.9% to prevent overheating of the bone margins and to remove the bone debris. Grafts were moulded into the defect using a small spoon and spatula. Incisions were closed in double layer by sutures and clamps, which were removed after 10 days. Animals were carefully monitored for behavioural abnormalities after the operation.  After 4 weeks, the rats were euthanized with CO2 followed by decapitation and the calvaria were stored and assessed as described below. 
Microtomography After explantation, samples were fixed in 4% paraformaldehyde overnight and then transferred to PBS. Microtomography was performed using a tungsten x-ray source at 70 kV and 260 PA with an aluminium filter of 0.5 mm (Nanotome, GE, USA). Transmission images were acquired for 360° with an incremental step size of 0.25°.  Volumes were reconstructed using a 
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modified Feldkamp algorithm (software supplied by manufacturer) at a voxel size of 2.5 – 15 
Pm. Thresholding, segmentation and 3D measurements were performed using the ImageJ(19) software with the BoneJ(20) and 3DShape(21) additions.  
Histology Samples were decalcified using a 7% EDTA 30% sucrose solution (Sigma-Aldrich, USA) and either embedded in paraffin for histological stainings or frozen in OCT for immunofluorescence.  Sections (5-10 Pm thick) were stained with haematoxylin and eosin (HE), Masson trichrome or Safranin-O. HE stained sections were used for the histological quantification of bone as described previously(22). In situ hybridization for human ALU sequences was performed as described previously(11) (PNAS 2014) to detect the presence of human cells. Immunohistochemistry and immunofluorescence were performed using primary antibodies for DIPEN (1042002, MDBiosciences, USA), type X collagen (ab49945), type II collagen (ab34712), MMP13 (ab39012), MMP9 (ab38898), CD31 (ab28364), human calcitonin receptor (ab175297, all from Abcam, UK) and human CD34 (CBL496, Dako, Denmark). Secondary antibodies labelled with Alexa Fluor 488, Alexa Fluor 546 or Alexa Fluor 647 (Invitrogen, USA) were used and DAPI (Sigma-Aldrich, USA) was used to stain nuclei in fluorescence images. Immunohistochemistry was done with biotinylated secondary antibodies (Dako, Denmark) and the Vectastain ABC kit (Vector Laboratories, USA). The Olympus BX61, BX63, Zeiss LSM 710 and Nikon A1R microscopes were used to acquire images.  
Statistical analysis  The data was visualized and analysed using the GraphPad Prism v. 6 software. Parametric ANOVA with the appropriate post-hoc tests as well as linear regressions were performed. P-values below 0.05 were considered to indicate statistically significant differences.  
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Results 
Devitalized hypertrophic constructs activated with SVF cells form ectopic bone Hypertrophic cartilage pellets engineered from human bone marrow-derived mesenchymal stromal cells (between 300 to 800 pellets for each of the five donors used) had an approximate diameter of 1-2 mm. Positive staining for glycosaminoglycans, type II and type X collagen (Figure 1A) were consistent with previously reported morphological and molecular features(15). After freeze/thaw devitalization, 12 pellets were suspended in a fibrin gel with or without the addition of human SVF cells (6 million cells/ml gel) and implanted into nude mice (Figure 1B). 
 
Figure 1. A: Representative staining of devitalized hypertrophic cartilage pellets. Saf-O = Safranin-O, CII = type II collagen, CX = type X collagen. Bars = 200um. B: Experimental setup for the generation of grafts, ultimately tested by implantation subcutaneously (nude mouse, ectopic model) or in calvarial defects (nude rat, orthotopic model).   After 12 weeks, control grafts in cell-free fibrin gel displayed depletion of glycosaminoglycans and only limited, scattered areas of remodelling into bone tissue (Figure 2A). Instead, SVF-activated grafts contained abundant osteoid matrix, embedding large areas occupied by bone marrow. In situ hybridization for human ALU sequences indicated that the SVF-activated grafts still contained human cells after 12 weeks in vivo, in contrast to the non-activated, devitalized grafts (Figure 2A). A closer immunohistochemical analysis showed that both the activated and non-activated grafts were undergoing MMP-driven degradation of cartilage matrix leading to aggrecan cleavage, as signalled by detection of the major MMP 
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cleavage site DIPEN (Figure 2B). Thus, aggrecan depletion did not appear to be directly related with the efficiency of bone and bone marrow development, which occurred to a markedly higher extent following SVF cell-based activation. 
 
Figure 2. Ectopic bone formation of grafts based on devitalized hypertrophic cartilage pellets, embedded in fibrin gel without or with (+SVF) stromal vascular fraction cells from adipose tissue. A: Representative Hematoxilin and Eosin (HE), Masson-Tri-Chrome (Masson), Safranin-O (Saf-O) stainings and in situ hybridization for human ALU-sequences after 12 weeks in vivo. Bars = 200 Pm. B: Stainings for metalloproteinase (MMP)13 and MMP9, as well as for the N-terminal neoepitope at the major MMP cleavage site (DIPEN) after 12 weeks in vivo. Bars = 50 Pm. 
 
The number of SVF cells correlates with ectopic bone quantity We then assessed a possible dose-response in the effect of SVF cells. Up to 12 million cells/mL gel we identified a clear correlation between the number of SVF cells at implantation and the resulting amount of mineralized tissue, measured by microtomography (R2 = 0.347; P = 0.01; Figure 3A), or of bone matrix, quantified in histological sections (R2 = 0.546; P = 0.0025; Figure 3B). It should be highlighted that quantification of the total space covered by bone structures, including bone marrow cavities embedded within the osteoid trabeculae (Figure 3C), would lead to even more marked differences in the effect of SVF cells. The amount of bone 
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formation was similar or even reduced by graft activation with more than 12 million SVF cells/mL gel.  
SVF cells contribute to osteoclast-mediated matrix resorption  The number of implanted SVF cells correlated significantly with the density of TRAP positive osteoclasts, histologically quantified after 12 weeks in vivo (R2 = 0.31, P = 0.03; Figure 3D&E). Immunofluorescence staining for the human isoform of calcitonin receptor identified some multinucleated positive cells in the vicinity of the osteoid matrix even after 12 weeks in vivo (Figure 3F), especially in the conditions when a high number of SVF cells was used at implantation. These data suggest that activation of devitalized hypertrophic cartilage by SVF cells may enhance its resorption and that SVF cells could not only attract resident osteoclasts, but also offer a source for those. 
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Figure 3. Following ectopic implantation, the amount of mineralized bone volume, quantified by microtomography (A) or the area covered by bone tissue, assessed in histological slides stained by Hematoxilin&Eosin (HE) (B), was expressed as fold difference of the non-activated grafts and plotted vs the number of embedded SVF cells (n = 5-6 grafts assessed / group; * = P < 0.05). C: Representative microtomography sections, with pixels marked in red if beyond the selected density threshold (top line) and HE-stained sections (bottom line) used to generate the data displayed in A and B. Bars = 500 Pm. D: The density of osteoclasts, assessed by tartrate resistant acid phosphatase staining (TRAP), was plotted vs the number of embedded SVF cells (n = 3 grafts assessed per group). E: Representative TRAP staining. Bar = 50 Pm or 300 Pm (inset). F: Staining for human calcitonin receptor (hCTR, green fluorescence), indicating the direct contribution of SVF cells to osteoclast formation. Bar = 50 Pm. 
Specific SVF sub-populations of endothelial lineage correlate with total bone 
quantity Considering the phenotypic heterogeneity of freshly isolated SVF cells, we addressed whether the amount of mineralized tissue could be correlated with the delivered dose of specific 
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SVF sub-populations. Therefore, we analyzed data generated from graft activation by different SVF preparations (n = 9 donors) against cytofluorimetric analysis of their phenotype, performed in parallel using the markers CD31, CD34, CD146, CD90, CD105 and CD15. The ratio of mineralized volume to total volume correlated most strongly with the number of implanted CD31 CD34 CD146 triple positive cells (R2= 0.4756; P = 0.013; Figure 4A), which identify endothelial cells. No correlation was found with CD90 (R2= 0.0226; P = 0.608; Figure 4B), CD105 (R2 = 0.0450; P = 0.467) or CD15 (R2 = 0.0616; P = 0.392) positive cells. Staining for DAPI, type X collagen and CD31 indicated that the activated grafts displayed a more advanced colonization of the hypertrophic matrix and a more uniformly organized vascular network than the non-activated grafts after 12 weeks in vivo (Figure 4C&D). Immunohistochemistry and immunofluorescence staining for the human isoform of CD34 indicated that some of the endothelial cells lining the vessels were of human origin (Figure 4E).  
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Figure 4. Plots of mineralized tissue volume (MV) / total tissue volume (TV) vs the percentage of embedded CD31+CD34+CD146+ (R2= 0.4756; P = 0.013) (A) or CD90+ SVF cells (R2= 0.0226; P = 0.608) (B). Dots represent single grafts. C&D: Representative immunofluorescence stainings for type X collagen (CX), CD31 and DAPI of devitalized samples without (C) or with SVF activation (D) after 12 weeks in vivo. Bars = 500 µm for left images and 200 µm for right images. E: Immunohistochemistry and immunofluorescence stainings for human CD3, identifying positive cells between remnants of hypertrophic matrix (HM). Bars = 50 
Pm.  
SVF-activated constructs enhance early orthotopic bone formation and 
bridging to host bone 
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To evaluate the orthotopic bone regenerative capacity of SVF activated grafts, we implanted devitalized hypertrophic cartilage pellets with or without (control) additional SVF cells (12 million/ml fibrin) into 4 mm rat calvarial defects (Figure 1B). After 4 weeks, calcified volume inside the defects was nearly identical (Figure 5A). However, more rigorous histological analysis revealed that the percentage of defect area filled by bone matrix was up to 7-fold larger in the SVF activated than in the non-activated grafts (P < 0.0001; Figure 5B), with osteoid formation also reaching the center of the defect (Figure 5C,D). Higher magnification assessments indicated that bone formation in the SVF-activated group was developing by (i) remodelling of the pellets into trabecular bone organoids and (ii) merging of those modular structures with each other and with the rat calvarium surrounding the defect (Figure 5E). Both processes could not be recognized in the non-activated grafts, also due to the minimal amounts of bone formed at the time point of observation. In some areas of implants activated by SVF cells, human origin cells could be observed inside the osteoid matrix, including the areas corresponding to newly formed bone marrow sinusoids (Figure 5F). 
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Figure 5. Bone repair capacity of devitalized hypertrophic cartilage pellets, embedded in fibrin gel without (dev) or with (dev+SVF) stromal vascular fraction (SVF) cells from adipose tissue, following implantation in rat calvarial defects. A: Mineralized volume quantified by microtomography (n = 9 grafts assessed / group). B: Bone area assessed in histological sections, expressed as percentage of total defect area (n = at least 24 sections assessed / group). **** = P < 0.0001. C&D: Representative 3D microtomography reconstructions (left) and Hematoxili/Eosin (HE) stainings (right) of the calvarial defects filled with devitalized grafts, implanted without (C) or with (D) activation by SVF cells after 4 weeks. Dotted circles indicate the defect borders (4mm diameter). Bars = 500 µm. E: Microtmography (left) and HE staining (middle & right) displaying the bridging between hypertrophic matrix and bone of the calvarium, or the fusion of single pellets (right). White bar = 850 µm. Black bars = 500 µm. Dotted lines indicate the edge of the calvarium. F: In situ hybridization for ALU sequences showing the presence of human cells in the explants. Bar = 200 µm. 
 
Discussion In this study we investigated the bone forming capacity of constructs generated by the combination of devitalized engineered hypertrophic cartilage pellets with freshly isolated SVF 
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cells from human adipose tissue. SVF activation of the hypertrophic cartilage strongly enhanced its bone formation efficiency, tested in subcutaneous ectopic implantation and calvarial defect models. In particular, the density of SVF cells was correlated with that of osteoclasts in the grafts, and the percentage of SVF-derived endothelial lineage cells was correlated with the amount of deposited mineralized matrix.  
The concept of using multiple pellets formed by chondrogenic differentiation of human MSC for the engineering of bone substitute materials has been previously proposed for the treatment of segmental bone defects in immunodeficient mice(7) or rats(5). In both studies, the cartilage grafts resulted in the generation of vascularized bone tissue, thereby supporting that recapitulation of endochondral ossification is a valid strategy for bone repair at orthotopic sites. However, despite the overall good performance, limited integration across the implanted pellets was observed(7), indicating that scaling up bone graft materials by the principle of bringing together smaller modules may require further improvement. Moreover, the implantation of living tissues required the use of autologous cells, with associated cost and logistics issues. 
In this context, the here described possibility of using engineered and then devitalized hypertrophic cartilage pellets would offer the distinct advantage of having ‘off	  the	  shelf’	  units, possibly engineered by allogeneic cells. Our results indicate that the MSC-deposited, cell-free extracellular matrix does contain the cues to trigger bone and bone marrow formation, and that its effect is strongly potentiated by the activation through living progenitors derived from fat tissue. Interestingly, we observed highly efficient integration among the different pellets and with the surrounding bone areas. This could be due to the presence of a gel embedding the pellets, which would allow the ingrowing cells or the seeded SVF cells to interconnect the structures during the remodelling process. 
One relevant contribution of SVF cells was demonstrated to be related to the endothelial subpopulation that they include. In fact, SVF-activated grafts qualitatively displayed a more uniformly organized vascular network and the presence even 12 weeks after implantation of 
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human endothelial cells, both within and around the implanted pellets. Moreover, a quantitative correlation could be established between the amount of mineralized matrix formed and the density of delivered endothelial cells, phenotypically identified as expressing CD31, CD34 and CD146(23-25). Our data are consistent with the previously recognized role of SVF cells in enhancing and directly contributing to vascularization of engineered tissues(18, 26) or even of avital cortical bone(27). 
An increasing number of delivered SVF cells was associated with a higher density of chondroclasts/osteoclasts in the grafts. These cells were in part of human origin, thus derived from the monocytic population of the SVF, and in part from the host, likely recruited thanks to the enhanced blood vessel invasion. A moderate increase in the density of osteoclasts from baseline values, achieved by the delivery of 12 million SVF cells / mL gel, could have been pivotal in enhancing the efficiency of bone formation. In fact, osteoclasts would mediate release of cytokines and morphogens contained in the devitalized hypertrophic cartilage, in turn activating resident osteoprogenitor cells. On the other hand, a larger increase in the density of osteoclasts, corresponding to the delivery of 24 million SVF cells / mL gel, was associated with a reduced bone formation. It is possible that excessive graft colonization by osteoclasts at early time points, as previously observed upon delivery of VEGF(28), would disrupt bone homeostasis towards excessive degradation, ultimately resulting in more limited net amounts of bone matrix.  
Although SVF cells contain progenitors for osteoblasts, their direct contribution to the osteoid formation appeared to be rather marginal. The fact that SVF cell delivery strongly enhanced the total density of osteoblastic cells ultimately forming abundant bone matrix suggests their role in recruiting local osteoprogenitors through the paracrine effect of trophic factors. An analogue mode of action was recently proposed for Wharton Jelly-derived mesenchymal progenitors, upon implantation in a calvarial defect(29). Importantly, ectopic implantation of freshly harvested SVF cells in combination with calcium phosphate-based materials was previously reported to yield dense connective tissue but no bone formation(30), 
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unless BMP-2 was additionally delivered(31). These findings underline the strong regulatory/inductive role of the devitalized hypertrophic extracellular matrix as compared to ceramic materials in the process of ossification.  
In our study, hypertrophic cartilage matrix was engineered starting from bone marrow-derived MSC and subsequently devitalized. Gawlitta et al. previously proposed the use of decellularized xenogenic cartilage-derived matrix particles, also incorporated within a gel material in combination with MSC(32), and found that it induced no increase in bone tissue formation. The difference from our findings may be related to the use of articular as opposed to hypertrophic cartilage, whereby the former is phenotypically stable and developmentally not competent to support bone formation. The general approach of using engineered instead of native tissue as a source of devitalized extracellular matrix could be associated with additional advantages. In fact, an engineered matrix may be customized and enriched in defined factors (e.g., osteoinductive, angiogenic or chemotactic cues) by using (i) specific culture medium supplements, (ii) cells transduced to undergo apoptosis upon exposure to chemical agents, thereby achieving a devitalization with better preservation of the matrix(11) and/or (iii) customized cells lines engineered to express larger amounts of the target factors(10). Finally, it would be tempting to speculate that a devitalized extracellular matrix can be most effective in instructing formation of bone if it does not derive from the fully developed tissue, but rather from the earlier stages of its development, as it is the case for hypertrophic cartilage(33). 
Conclusions Our findings support a novel strategy for bone repair or augmentation, whereby allogeneic hypertrophic cartilage is engineered, devitalized, and then clinically used as an off-the-shelf material in combination with autologous SVF cells, intraoperatively derived from a lipoaspirate. Manufacturing of hypertrophic cartilage could take place within bioreactor systems, whereby biological processes could be monitored, controlled, automated and standardized(34). Towards 
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clinical fruition, further studies are necessary in more relevant animal models, which should include the critical factors of immunocompetence and mechanical loading. 
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Conclusion and Perspective 
The aim of my thesis was to validate the use of in vitro engineered hypertrophic cartilage as a 
bone substitute. I explored two available options for a rapid clinical translation. First, I engineered 
hypertrophic cartilage from bone marrow derived mesenchymal stromal cells for autologous use. I 
identified a suitable production method for the generation of large grafts and a way of monitoring 
and assuring the quality of the resulting grafts. Second, I produced allogeneic hypertrophic grafts, 
devitalized them and seeded them with different cell types to enhance their osteoinductive 
properties.  
Hypertrophic cartilage was generated in a perfusion bioreactor system with rabbit bone marrow 
derived mesenchymal stem cells and in vivo bone formation was tested in order to generate 
protocols and guidelines for a future pre-clinical trial in a rabbit orthotopic model. 
Glycosaminoglycan and alkaline phosphatase content in culture supernatants were monitored to 
collect information on tissue integrity and maturity. The monitored parameters correlated with 
tissue quality and in vivo bone formation. This correlation might be used to maximize the efficiency, 
reproducibility and most importantly quality of the manufacturing process.  
A major difficulty of autologous use was the variability of cartilage formation with different 
rabbit donors, which is in line with reports in human MSCs. To address this issue, pre-production of 
allogeneic devitalized tissue was considered. Engineered hypertrophic matrix subjected to different 
modes of devitalization was characterized for preservation of growth factors and components of the 
extracellular matrix and in vivo bone formation. It was demonstrated that suitably devitalized matrix, 
could deliver the set of factors necessary to induce formation of bone and bone marrow. The findings 
outlined a paradigm relying on the engineering of cell-based but cell-free niches, which could recruit 
and instruct endogenous cells to form predetermined tissues.  
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Devitalized constructs remained inferior to vital ones, which could be due to a deficient 
remodelling by host cells. To actively stimulate tissue degradation, thus releasing chemoattractant 
factors and ultimately improving bone formation, osteoclastogenic monocytes were seeded on both 
living and devitalized matrix. In vitro, the formation of osteoclasts, the secretion of factors in 
supernatants, the attraction of monocytes, endothelial cells or mesenchymal stem cells and the 
differentiation of mesenchymal stem cells in the presence of secreted factors were analyzed. In vivo, 
the presence of osteoclasts, macrophages, endothelial cells and mesenchymal stem cells was 
described at an early time point, as well as the bone formation at a late time point. In vitro and in 
vivo the observations were consistent. No improvement of bone formation was observed in living or 
devitalized grafts. MSC were not attracted and vascularization was only correlated with the presence 
of recruited M2 macrophages. While monocytes could be attracted by devitalized matrix, their 
survival and differentiation into osteoclasts strongly depended on interactions with hypertrophic 
chondrocytes.  
As a way to provide multiple progenitor lineages and enhance bone formation, stromal vascular 
fraction (SVF) cells from human adipose tissue were used. Multiple pellets of devitalized matrix were 
combined together with different amounts of SVF and implanted subcutaneously. The contribution 
of SVF to the bone formation, vascularization and bone resorption was analyzed. SVF activation of 
the hypertrophic cartilage strongly enhanced the bone formation efficiency, both in subcutaneous 
ectopic implantation and calvarial defect models. In particular, the density of SVF cells was correlated 
with that of osteoclasts in the grafts, and the percentage of SVF-derived endothelial lineage cells was 
correlated with the amount of deposited mineralized matrix. These findings support a novel strategy 
for bone repair or augmentation, whereby allogeneic engineered and devitalized hypertrophic 
cartilage is clinically used as an off-the-shelf material in combination with autologous SVF cells.  
Taken together, the results of my thesis provide a stepping stone for the use of hypertrophic 
cartilage as a tool for bone regeneration. The presented manufacturing process using monitored 
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bioreactor systems allows a controlled and standardized production of hypertrophic cartilage. The 
resulting tissue could be used as is, cut to a specific shape or minced to provide a bone-filling 
granulate. However, to satisfy clinical demand an up-scaled bioreactor-based production system 
using human MSC will have to be developed. The proposed monitoring parameters could then be 
used to establish suitable product quality and release criteria. The described variability in cartilage 
formation will need to be better understood and addressed with appropriate changes to the culture 
protocol.  
The collected insights in the process of remodelling could guide the engineering of hypertrophic 
matrix to further enhance osteoinductivity.  Yet, the limited understanding of cellular and molecular 
mechanisms regulating efficient endochondral bone formation still needs to be expanded. For 
example, neutrophils present during fracture and wound healing may have a significant effect on the 
implanted hypertrophic cartilage. The role of macrophages polarized towards a regenerative 
phenotype (M2) needs to be further characterized. Pivotal to tissue engraftment, the kinetics and 
regulation of vascularization appear to be significantly different in implanted hypertrophic cartilage 
compared to other grafts and require further studies. The attraction of mesenchymal stromal cells 
and their interaction with osteoclasts and macrophages is not well understood in endochondral 
ossification and could be crucially influenced by signals from the hypertrophic matrix. During long-
term remodelling, immunoregulatory mechanisms absent from the nude mouse/rat model, such as 
T-regulatory cells or antibodies, could have a significant impact on bone formation. The effect of 
mechanical stress on remodelling, e.g. in a load-bearing orthotopic site, also remains to be 
elucidated.  
The large volume of bone marrow resulting from the remodelling of hypertrophic cartilage has 
been shown to harbour haematopoietic stem cells(2). This opens the possibility to engineer the 
signals provided by the hypertrophic cartilage and thus carefully dissect the formation of the 
physiological or pathological haematopoietic niche. Intriguingly, a better understanding of the 
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remodelling process could lead to in vitro controlled bone marrow formation and haematopoiesis 
using the 3D culture system presented here (3).  
Finally, a cell-line with reproducible behaviour could be generated for superior biological 
performance and customization of the matrix to actively drive tissue repair (1). 
In order to develop a commercial osteoinductive off-the-shelf material, devitalized tissue using 
the proposed soft devitalization method would have to be extensively tested to ensure that no safety 
concerns remain regarding the host immune reaction, transmission of diseases and tumor formation. 
On the other hand, the use of freeze/thaw devitalized hypertrophic cartilage with autologous SVF 
could be a faster alternative, since no genetic manipulation of cells and therefore less extensive 
testing is required. Indeed, a recent clinical trial of the feasibility and safety of intraoperative SVF 
application in humeral fractures (ClinicalTrials.gov: NCT01532076) used a silicated calcium phosphate 
carrier material and showed de novo ossicle formation. To use freeze/thaw devitalized hypertrophic 
cartilage as carrier material instead, it would be required to test the immunological reaction in 
immunocompetent animals and to guarantee a safe and regulatory compliant production.  
In conclusion, although further in-depth studies in more relevant animal models are necessary, 
clinical application of the herein explored strategies may be within reach during the current decade.  
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